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ABSTRACT 
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM THROUGHOUT 
THE ESTROUS CYCLE AND DURING THE ATTAINMENT OF PUBERTY IN 
GILTS 
ERIC STEVEN JOLITZ 
2016 
 Kisspeptin has been demonstrated to affect reproductive cyclicity and the 
attainment of puberty in multiple species, presumably through its actions on GnRH and 
LH, as demonstrated in other species. Kisspeptin administration causes increased plasma 
concentrations of LH in pigs, sheep, and rats. Two experiments were conducted to 
evaluate 1) the hypothalamic kisspeptin system throughout various days of the estrous 
cycle and 2) the hypothalamic kisspeptin system during the peripubertal period in gilts. In 
experiment 1, 40 crossbred gilts (191 d, 121 kg) were administered an intramuscular 
injection of PG600. Twelve days after the administration of PG600, gilts were fed 15 mg 
of altrenogest daily for 15 d to synchronize estrus. Following estrus synchronization, 
estrus detection was performed by exposing gilts to a mature boar and the first day gilts 
stood immobile was denoted d 1 of the estrous cycle. Blood samples were collected via 
jugular venipuncture on d 1, 4, 7, 9, 14, 16, and 19 of the estrous cycle. Ten animals were 
slaughtered on d 1, 9, 14, and 21 of the estrous cycle when MBH, AP, and blood were 
collected. Relative expression of hypothalamic Kiss1, Kiss1R, ER-, ER- and -actin 
was determined using real-time reverse transcriptase PCR. Fold changes in relative 
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expression were determined using the Relative Expression Software Tool. Relative 
expression of Kiss1 was increased (P=0.006) 3.2 fold on d 1 versus d 21 and (P=0.003) 
2.3 fold on d 9 versus d 21 of the estrous cycle. Relative expression of Kiss1 was not 
different (P>0.05) among the remaining days. Relative expression of ER- was decreased 
(P=0.05) 0.8 fold on d 9 versus d 21 and (P=0.005) 0.7 fold on d 14 versus d 21. Relative 
expression of ER- was not different (P>0.05) among the remaining days. Relative 
expression of Kiss1R and ER- were each not different (P>0.05) among days. In 
experiment 2, two studies were performed, each with 25 crossbred gilts (151 d, 105 kg). 
In study 1 gilts were slaughtered on d 7 and in study 2 gilts were slaughtered on d 8. Gilts 
were relocated and exposed to a mature boar throughout study to naturally induce 
puberty. Gilts that stood immobile within 24 hours of slaughter were considered to have 
attained puberty (n=8/study). Plasma samples were collected on d 1, 3, and 7 of the first 
study and d 2, 4, 6, and 8 of the second study. When gilts were slaughtered in both 
studies, MBH, AP, and blood were collected. Relative expression of MBH Kiss1 and 
actin and AP GnRHR, LH-, and actin was determined using real-time reverse 
transcriptase PCR. Fold changes in relative expression were determined using the 
Relative Expression Software Tool.  Hypothalamic and AP content of kisspeptin were 
determined by RIA and differences were determined using the GLIMMIX procedure of 
SAS. Relative expression of Kiss1 was increased (P=0.005) 2.2 fold in the gilts that had 
attained puberty in the first study, however, was not different (P=0.16) when comparing 
treatments in the second study. Relative expression of GnRHR was not different (P>0.05) 
between treatments in both studies. Relative expression of LH- tended to be decreased 
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(P=0.09) 0.80 fold in the first study but was not different (P=0.19) in gilts that attained 
puberty in the second study. AP concentrations of LH were not different (P=0.35) 
between treatments in the first study and were decreased (P=0.01) in gilts that attained 
puberty in the second study.  AP concentrations of kisspeptin were not different (P=0.43) 
in the first study but were increased (P=0.04) in gilts that had attained puberty in the 
second study. MBH concentrations of kisspeptin were increased (P=0.03) in gilts that had 
attained puberty in the first study but were not different (P=0.68) between treatments in 
the second study. These data further support the notion that MBH expression of Kiss1 
and concentrations of kisspeptin and AP concentrations of kisspeptin influence 
reproductive cyclycity and the attainment of puberty in the gilt.  
Keywords: Kisspeptin; Kisspeptin Receptor; Hypothalamus; Pituitary; Pig 
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Chapter 1 
Literature Review  
Kisspeptin background 
Kisspeptin has been demonstrated to play a pivotal role in many physiological 
functions, including reproduction and the growth of proliferating cells. First discovered in 
1996 in Hershey, PA, the Kisspeptin1 gene (Kiss1) was termed a metastasis-suppressor 
gene due to its anti-oncogenic growth characteristics in the human (Lee et al., 1996). 
Since 1996, kisspeptin has been extensively demonstrated to also play a major role in 
reproduction through its actions on GnRH in a number of mammalian and non-
mammalian species (Abbara et al., 2013; Clarkson et al., 2008; Colledge and 
d'Anglemont de Tassigny, 2010; Decourt et al., 2008; Elizur, 2009; Franceschini et al., 
2006; Hrabovszky et al., 2007; Seminara et al., 2003; Tobari et al., 2010). Its actions on 
GnRH may be of importance during the attainment of puberty, estrous cycle and may 
have effects during pregnancy, parturition, lactation, and the postpartum recovery period 
in pigs (Caraty et al., 2007; Castellano et al., 2005; Clarkson, 2013).  
Past research has indicated that the Kiss1 and the Kiss1-receptor gene (Kiss1R) 
are highly expressed throughout many tissues in pigs (Li et al., 2008). Li et al. (2008) 
analyzed 18 tissues for the presence of Kiss1R transcripts and found it was particularly 
abundant in the adrenal, prostate, testis, thymus, pituitary, and hypothalamus. Because 
the Kiss1R is present in so many tissues throughout the body it is likely that kisspeptin 
affects many physiological processes throughout the body.  
 
 
 
2 
 
The Kiss1 gene encodes the pre-prohormone Kisspeptin-234 (Kp-234), which is 
biologically inactive in mammalian and non-mammalian species (Ronnekleiv and Kelly, 
2013). Kisspeptin-234 is cleaved into one of four biologically active forms that can bind 
to the Kiss1-receptor. The four biologically active forms of kisspeptin in mammalian 
species are Kisspeptin-54 (Kp-54), Kisspeptin-14 (Kp-14), Kisspeptin-13 (Kp-13), and 
Kisspeptin-10 (Kp-10). Amino acid sequences of these four proteins are highly conserved 
among mammalian species (Kotani et al., 2001; Ohtaki et al., 2001). The carboxy-
terminus is the most highly conserved region among all mammalian species and confers 
the biological activity of kisspeptins (Colledge, 2008; Pasquier et al., 2014). Also, the 2, 
4, 6, 7, 8, and 9 amino acids are completely conserved across mammalian species 
sequenced to date (Pasquier et al., 2014). The kisspeptin isoforms vary in length among 
mammalian species (De Bond and Smith, 2014). 
Kisspeptins bind to their cognate receptor with high affinity. The Kiss1R gene 
encodes the Kiss1 derived protein receptor (GPR54), which is 398 amino acids in length. 
Kisspeptin1 derived protein receptor is a G-protein coupled receptor (GPR) (Pasquier et 
al., 2014) and acts through the classical GPR pathway. When the biologically active 
kisspeptins bind to GPR54, intracellular metabolic pathways including protein kinase are 
activated (Glanowska and Moenter, 2015; Liu et al., 2008). All of the four biologically 
active forms of kisspeptins can bind to GPR54. 
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Site of action of kisspeptin and its actions on GnRH 
Gonadotropin releasing hormone (GnRH) is important for successful reproduction 
in numerous mammalian and non-mammalian species. This decapeptide has been shown 
to have actions in the hypothalamus through ultra-short feedback, however its actions are 
primarily in the AP causing the synthesis and release of the gonadotropins LH and FSH 
(Cai and Zhang, 2005; Jackson et al., 2013; Karsch and Evans, 1996). Gonadotropin 
releasing hormone neurons are highly abundant in the hypothalamus in many species 
including the pig (Silverman et al., 1987; Silverman et al., 1979). In most mammalian 
species including the pig, there are two particular regions of interest: the surge center and 
the tonic center, which control the release of GnRH.  
Though it is plausible that kisspeptin elicits the release of hormones in many 
tissues in the body, it is thought that its main actions are within the hypothalamus to 
cause the release of GnRH and subsequent gonadotropin release. In the presence of a 
GnRH antagonist the stimulatory effects of kisspeptin on gonadotropin release are 
attenuated in female mice, rats, sheep, and monkeys (Matsui et al., 2004; Navarro et al., 
2005; Plant et al., 2006; Roseweir et al., 2009; Smith et al., 2011). Peripheral 
administration of kisspeptin-54 has been shown to activate GnRH neurons in the 
hypothalamus (Caraty et al., 2007). Peripheral administration of kisspeptin to sheep 
caused an increase in GnRH concentrations in the cerebrospinal fluid (CSF) in sheep 
(Matsui et al., 2004; Messager et al., 2005).  
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Data also support the implication that kisspeptin acts on GnRH neurons due to the 
anatomical intimacy between GnRH neurons and kisspeptin receptors. The 
neurohormone kisspeptin is thought to elicit the release of GnRH via an intimate 
connection of kisspeptin neuronal axons associated with dendrites of GnRH neurons 
(Hrabovszky et al., 2007). This was discovered through double-immunostaining for 
kisspeptin and GnRH neurons (Hrabovszky et al., 2007). Research has also indicated that 
GPR54 is expressed by GnRH neurons and is directly stimulated by kisspeptin to cause 
GnRH release (Muir et al., 2001; Navarro et al., 2004). More than 70% of GnRH neurons 
are co-expressed with kisspeptin receptor mRNA in the rat hypothalamus (Irwig et al., 
2004). In the rat, it has also been demonstrated that kisspeptin immunoreactive nerve 
elements directly adjoin to GnRH nerve elements in the hypothalamus (Uenoyama et al., 
2011). It has also been shown that kisspeptin stimulated the release of GnRH from rat 
hypothalamic explants (Thompson et al., 2004). These data indicate that kisspeptin may 
stimulate the release of GnRH from GnRH neurons in certain areas of the hypothalamus 
(Uenoyama et al., 2011).  
While it is thought that the predominant actions of kisspeptin are in the 
hypothalamus through its actions on GnRH neurons, it has also been thought that 
kisspeptin may act directly on the anterior pituitary gland (AP). In AP cell cultures from 
adult female baboons, kisspeptin elicited the release of LH in a dose-dependent manner 
(Luque et al., 2011). Kisspeptins have been demonstrated to elicit the release of LH and 
FSH from the AP in nonmammalian vertebrates (Elizur, 2009; Tobari et al., 2010), 
rodents (Revel et al., 2006), ungulates (Decourt et al., 2008; Franceschini et al., 2006; Li 
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et al., 2008; Magee et al., 2009; Ohkura et al., 2009; Pompolo et al., 2006), and primates 
(Hrabovszky et al., 2007; Seminara et al., 2003). It is thought that kisspeptins act through 
direct association with GnRH neurons as well as kisspeptins release into the 
hypothalamohypopheseal vascular plexus to associate with the gonadotrophs directly 
(Dungan et al., 2006; Ezzat et al., 2010). Additionally, estradiol-17 (E2) increased the 
release of LH from AP cells when treated with kisspeptin (Luque et al., 2011). Similarly, 
in the rat, another study indicates that when rat anterior pituitary cells were incubated 
with kisspeptin-10, LH was increased in a dose dependent manner (Navarro et al., 2005). 
On the contrary, Thompson et al. (2004) demonstrated that there was no release of LH 
from cultured anterior pituitary cells during treatment of pharmacological doses of 
kisspeptin in the rat. Another study in female and male rats indicated that when 
kisspeptin-54 was incubated with cultured anterior pituitary cells there was no in vitro 
LH or FSH release, even after the pituitary cells were primed with E2 (Matsui et al., 
2004). Though kisspeptins have some effect on the release of the gonadotropins from 
cultured anterior pituitary cells, research seems to be equivocal as to whether kisspeptin 
acts on the AP directly.  
Lents et al. (2008) administered kisspeptin-10 peripherally and centrally to pigs 
and reported that it caused an increase in circulating concentrations of LH. Anterior 
pituitary cultures from the bovine and porcine species elicited LH release in response to 
kisspeptin in a dose dependent manner, however, pharmacological doses were required 
(Suzuki et al., 2008). Suzuki et al. (2008) also demonstrated that LH release occurred 
within cultured AP cells in response to physiological doses of GnRH. This supporting 
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evidence suggests that in addition to GnRH, kisspeptin may also increase the release of 
LH through the GnRH pathway (Messager, 2005). 
 Kisspeptin-54 is a key hormone influencing the regulation of reproductive 
function and development (Adachi et al., 2007; Gottsch et al., 2004). Centrally 
administered kisspeptins stimulate the release of GnRH in prepubertal and pubertal 
female mice and rats (Gottsch et al., 2004; Kinoshita et al., 2005). There is also 
supporting evidence that in Kiss1R knockout mice, kisspeptin is not able to stimulate the 
release of FSH and LH which is thought to be through the GnRH pathway (Messager et 
al., 2005). Additionally, during treatment with acyline, a potent GnRH antagonist, the 
kisspeptin-mediated release of LH was completely inhibited (Gottsch et al., 2004). 
During ICV treatment with kisspeptin there was an increase in the release of GnRH in the 
mouse (Messager et al., 2005). When kisspeptin is incorporated with GnRH neurons in 
vitro, there is a potent increase in GnRH neuronal firing (Han et al., 2005; Zhang et al., 
2008).  These data support the notion that the stimulatory actions of kisspeptin seem to be 
mainly on GnRH neurons.  
 Over the past decade there have been a multitude of publications pertaining to the 
influence of Kiss1 and kisspeptins and the regulation of GnRH secretion (Gottsch et al., 
2004; Messager et al., 2005; Novaira et al., 2009). In addition to the association between 
Kiss1, kisspeptin, and GnRH, there have also been studies describing the regulation of 
the expression of hypothalamic Kiss1 in correspondence with E2 in mice and rats (Oakley 
et al., 2009; Smith et al., 2005a). An increase in E2 causes an increase in the expression of 
hypothalamic Kiss1 in the anteroventral periventricular nucleus (AVPV) but decreases 
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the expression of hypothalamic Kiss1 in the arcuate nucleus (ARC) in the female mouse 
(Smith et al., 2005a; Smith et al., 2006b). The location in which the expression of 
hypothalamic Kiss1 is up-regulated is of importance because the positive feedback 
effects of E2 are primarily exhibited on the AVPV in rodent species (Petersen and 
Barraclough, 1989; Wiegand et al., 1980).  
Although correspondence of the expression of hypothalamic Kiss1 and E2 is true 
in mice and rats, the concept in sheep is somewhat different. In sheep, the primary region 
that receives positive feedback of E2 is the preoptic area (POA) indicating that the basal 
and mediobasal hypothalamus (MBH) may be sufficient in maintaining the steroid-
mediated release of GnRH (Caraty et al., 1998). Regardless of the region of regulation of 
the expression of hypothalamic Kiss1 by E2 in the brain, kisspeptin potently excites 
GnRH neurons in all instances indicating that specific areas within the hypothalamus may 
be influenced by kisspeptin and involved in the release of GnRH and LH.   
Mechanisms by which E2 and progesterone (P4) feed back to the hypothalamus 
and AP are also of great importance in the control of GnRH and the LH surge. For the 
GnRH surge to occur there have to be threshold concentrations of E2 in the absence of P4 
(Clarke and Cummins, 1984; Everett and Sawyer, 1950; Harris et al., 1999; Moenter et 
al., 1993; Richter et al., 2001). Past research is equivocal as to whether GnRH neurons 
express E2- and P4-receptors in mammalian species. Gonadotropin releasing hormone 
neurons do express estrogen receptor-beta (ER-) in humans (Hrabovszky et al., 2007). 
This supports the notion that E2 can directly affect GnRH neurons thus changing the 
animals’ endocrine status. However, it is thought the ER- receives the signals for 
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negative estrogen feedback when positive feedback through estrogen receptor-alpha (ER-
 is needed for the GnRH surge to occur in the mouse (Glidewell-Kenney et al., 2007). 
In the female mouse there are positive, but not negative, feedback actions of E2 through 
ER- in kisspeptin neurons (Dubois et al., 2015). It has not been demonstrated that 
GnRH neurons express ER- (Herbison and Theodosis, 1992; Lehman and Karsch, 
1993). Therefore, other neurons upstream of GnRH neurons that possess ER- have been 
considered as possible mediators of steroidal effects on GnRH release. 
Dual immunofluorescence revealed that neurons containing kisspeptin-10 
expressed ER- (Franceschini et al., 2006). The majority of cells expressing kisspeptin 
neurons co-expressed progesterone receptors (PR) in the ARC in sheep (Smith et al., 
2007). Regulation of the expression of hypothalamic Kiss1 is likely to be a mediator of 
negative feedback in multiple species (Adachi et al., 2007; Franceschini et al., 2006; 
Goodman et al., 2007; Smith et al., 2005a; Smith et al., 2005b). There is also supporting 
evidence that reduced activity of kisspeptin neurons in the hypothalamus of many 
mammalian species is responsible for the relay of negative feedback effects of E2 to 
GnRH neurons. Castrated male and ovariectomized (OVX) female mice had increased 
levels of the expression of hypothalamic Kiss1 versus gonadally intact female mice 
(Smith et al., 2005a; Smith et al., 2005b).  There was also an increase in the expression of 
hypothalamic Kiss1 in OVX sheep and primates versus controls (Pompolo et al., 2006; 
Rometo et al., 2007; Shibata et al., 2007). During estrogen administration to OVX female 
sheep, the expression of hypothalamic Kiss1 returns to levels not different from control 
animals after not being administered estrogen (Pompolo et al., 2006; Rometo et al., 2007; 
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Shibata et al., 2007). The expression of ARC Kiss1 was increased, however the 
expression of POA Kiss1 was decreased in OVX ewes (Smith et al., 2007). Intact ewes 
that exhibited normal steroid feedback had decreased expression of hypothalamic Kiss1 
during times of anestrous (Smith et al., 2007). Moreover, the number of kisspeptin 
positive cells in the ARC of OVX ewes was reduced by treatment of E2 and P4 (Smith et 
al., 2007). Kisspeptin neurons are associated with ER-, PR, and androgen receptors and 
therefore have the potential to relay steroidal feedback effects onto GnRH neurons 
(Dubois et al., 2015; Roseweir and Millar, 2009). Though exact mechanisms are 
unknown, these data suggest that steroids can regulate the expression of hypothalamic 
Kiss1, thereafter stimulating GnRH neurons. 
Effects of acute kisspeptin administration on LH secretion 
 Luteinizing hormone, and the preovulatory LH surge are of utmost importance for 
mammals to successfully reproduce. In most instances during peripheral, intravenous 
(i.v.), and central acute administration, kisspeptin has been shown to stimulate 
gonadotropin release. Though kisspeptin has been shown to act primarily in the 
hypothalamo-pituitary axis with very low circulating levels in the blood, peripheral 
administration of kisspeptin has been demonstrated to consistently stimulate the release 
of gonadotropins in a number of mammalian species.  
 The plasma half-life of Kisspeptin-10 in vivo is very short - only 4 minutes in the 
human (Jayasena et al., 2011). Kisspeptin-54 also has a short in vivo plasma half-life of 
about 25 minutes in the human (Dhillo et al., 2005). Therefore, i.v. administration of 
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kisspeptin-10 would be expected to have a short duration of effects and/or may need to be 
administered at pharmacological levels to elicit the release of gonadotropins. Matsui et al. 
(2004) demonstrated that a subcutaneous administration of 6.7 nmol of human kisspeptin-
54 in pre-pubertal female rats elevated plasma LH levels 10-fold from baseline levels 2 
hours after injection. Additionally, administration of kisspeptin-54 caused ovulation in a 
large percentage of follicles, similar to the effects of human chorionic gonadotropin 
(hCG) (Matsui et al., 2004). It has also been demonstrated that male rats (10 weeks of 
age) that were administered subcutaneous equimolar doses of kisspeptin-54 and GnRH 
responded to the two hormones in almost an identical fashion, indicating that kisspeptin-
54 and GnRH are equally effective at stimulating the release of LH (Thompson et al., 
2009).  
 During central and peripheral administration of kisspeptin-10 in GnRH-primed, 
castrated rhesus monkeys, researchers observed that 100 g of kisspeptin-10 
administered both centrally and peripherally induced the release of LH (Shahab et al., 
2005). During both ICV and i.v. infusions plasma concentrations of LH increased more 
than 20-fold by 30 minutes after the start of kisspeptin-10 infusion and continued to be 
elevated for approximately 2 hours (Shahab et al., 2005). However a smaller dose of 30 
g kisspeptin-10 stimulated LH secretion in a lesser manner (Shahab et al., 2005).  
 The effects of i.v. administration of kisspeptin-10 were also studied in livestock 
species. Human kisspeptin-10 was infused intravenously into pubertal, female goats in 
the luteal phase in a dose dependent manner. Circulation concentrations of LH increased 
greater than 4-fold 20 to 30 minutes following infusion (Hashizume et al., 2010). 
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Similarly in cattle, an intravenous and intramuscular bolus of kisspeptin-10 at 100 and 
200 pmol/kg increased plasma LH levels 9.7- and 3-fold, respectively (Whitlock et al., 
2008). Additionally, an intravenous infusion of kisspeptin-10 at doses of 0.77, 1.54, and 
3.84 mol to pre-pubertal gilts stimulated an increase in LH to a similar degree following 
all doses (Lents et al., 2008). Therefore, kisspeptin-54 and -10 are effective in stimulating 
LH secretion whether given centrally, intravenously, intramuscularly, or subcutaneously 
to a number of species, including the pig.  
Kisspeptin and the estrous cycle 
The average estrous cycle of the pig is approximately 21 d in length of which the 
follicular phase and luteal phase are approximately 5 d and 16 d in length, respectively. 
The follicular phase is the time during which concentrations of E2 are increased and P4 
are decreased. Additionally, the GnRH and LH surge and ovulation occur during this 
period. During the luteal phase, serum concentrations of P4 are increased and serum 
concentrations of E2 are decreased. Corpora lutea (CL) are producing P4 during this phase 
and concentrations of E2 are decreased since there is a decrease in the pulsatility and 
amplitude of LH. Therefore, the follicular phase of the estrous cycle is of particular 
interest because it is a time coincident with increased hypothalamic concentrations of 
kisspeptin, the GnRH and LH surge, and the subsequent ovulation.  
The amplitude and frequency of LH release are of importance during normal 
reproductive cyclicity in mammals. In order for ovulation to occur LH has to reach a 
threshold level – this being termed the preovulatory LH surge. Past research indicates that 
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kisspeptin plays a pivotal role in the generation of the LH surge. During ICV infusion of 
kisspeptin-10 in the pig there was a LH surge (Pineda et al., 2010). Caraty et al. (2007) 
demonstrated that constant i.v. infusion of kisspeptin-10 for 8 h beginning 30 h after P4 
withdrawal, resulted in an earlier LH surge compared to ewes treated with a placebo 
infusion (Caraty et al., 2007). Intravenous infusion of kisspeptin-10 also stimulates an LH 
surge in anestrous ewes (Sebert et al., 2010). Ewes treated with Kiss1-receptor antagonist 
p-271 did not exhibit an E2 induced LH surge (Smith et al., 2007).  
Kisspeptin is thought to exert most of its actions in certain areas of the 
hypothalamus through the GnRH pathway. In vitro studies have shown kisspeptin to act 
at the level of the AP, but not in vivo studies. Cultures of ovine anterior pituitary cells 
responded to kisspeptin treatment exhibiting LH release in a dose dependent manner, 
however pharmacological doses of kisspeptin were required to elicit this response 
(Suzuki et al., 2008). Hypothalamo-pituitary-disconnected (HPD) ewes did not respond 
to kisspeptin-10 treatment as there was no difference in concentrations of LH versus ewes 
that did not have a HPD (Smith et al., 2008). There was an increase in the number of 
kisspeptin positive cells in the ARC and an increase in the expression of ARC and POA 
Kiss1 during the follicular phase in the ewe, a time coincident with ovulation (Estrada et 
al., 2006; Smith et al., 2007). Smith et al. (2009), also demonstrated that there was an 
increase in the percentage of kisspeptin cells in the ARC during acute administration of 
E2 in intact ewes versus OVX ewes administered a chronic dose of E2 the response in 
intact ewes was greater (Smith et al., 2009).  These data indicate that kisspeptin is 
seemingly obligatory for the generation of the GnRH surge and the subsequent LH surge. 
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However, it is unclear if kisspeptin acts at the level of the AP, in vivo, under normal 
physiological conditions.  
Kisspeptin and puberty 
The attainment of puberty and hormonal patterns that coincide with the attainment 
of puberty are important concepts to understand. There are many definitions indicative of 
puberty: the first time a female ovulates, the first time a female exhibits estrus, the first 
time the preovulatory LH surge occurs, and the first time a female can carry an 
embryo/fetus to term without it having deleterious effects to her body. Though there are 
advantages and disadvantages to each of these definitions, the first time a female stands 
in a natural estrus is one of the easiest to use from a research standpoint. 
In the gilt, age at puberty is positively correlated with age at first boar exposure 
(Filha et al., 2009). For best results, gilts are brought to boars where they interact with the 
boar through sight, sound, smell, and tactile stimulation. Past studies have shown that 
relocation followed by exposure to a mature boar can induce puberty in gilts without the 
use of exogenous hormones. Gilts also have to be of proper physiological maturity in 
order to attain puberty naturally. Puberty in the gilt, as described by the first preovulatory 
LH surge, is attained when there is a decrease in the sensitivity to the negative feedback 
effects of E2 which allows the LH surge to occur. During the first GnRH surge and 
subsequent LH surge the gilts hypothalamus shifts from being controlled in a negative to 
positive steroid feedback fashion. During relocation and boar exposure, this physiological 
shift can be achieved causing the subsequent natural attainment of puberty. As the gilt 
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attains puberty there is also an increase in FSH, which causes the development of 
follicles that synthesize microgram amounts of E2. These physiological factors contribute 
to the attainment of puberty in the gilt although the exact mechanisms by which these 
hormones are released is not fully understood. 
There are an abundance of hormones and growth factors that contribute to the 
attainment of puberty. Of those hormones and growth factors, kisspeptin and hormones 
associated with kisspeptin are of interest. Neurokinin B (NKB) is a tachykinin and has 
been demonstrated to have effects on the secretion of GnRH in the ewe (Goodman et al., 
2014). Neurokinin B is co-expressed with kisspeptin in a large number of hypothalamic 
cells in sheep indicating NKB may also play a role in the initiation of puberty (Nestor et 
al., 2012). When prepubertal ewes were injected with senktide, a NKB agonist, there was 
an immediate pulse of LH versus animals that were administered vehicle (Nestor et al., 
2012). Additionally, there was an increase in kisspeptin positive cells in the 
hypothalamus after the attainment of puberty in intact ewes as well as in prepubertal 
OVX ewes versus intact prepubertal ewes (Nestor et al., 2012). Peripheral administration 
of kisspeptin-10 caused an increase in circulating plasma concentrations of GH in 
prepubertal heifers (Nestor et al., 2012). Insulin-like growth factor I has been 
demonstrated to have positive effects on the LH surge in a number of species (Adam et 
al., 2000; Stewart et al., 1996). Insulin-like growth factor-I can also induce an increase in 
hypothalamic Kiss1 mRNA expression during the onset of puberty in the rat, although the 
signaling pathway by which this occurs remains elusive (Hiney et al., 2009). Hiney et al. 
(2009) demonstrated that when rats were administered alcohol, an IGF-I inhibitor, there 
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was a decrease in the expression of hypothalamic Kiss1. Rats that were administered 
IGF-I with saline instead of alcohol showed an increase in the expression of 
hypothalamic Kiss1 (Hiney et al., 2009). These data indicate that several physiological 
factors influence the hypothalamic kisspeptin system which may have implications 
during the attainment of puberty.  
Many mammalian species exhibit different hormonal patterns during central and 
peripheral infusion of when kisspeptin antagonists. Extensive in vitro and in vivo 
kisspeptin research has been conducted in a number of mammalian species, including the 
pig. During ICV infusion of kisspeptin antagonist (p-234) there was a decrease in LH 
pulse amplitude in the ewe – the level of LH was decreased to the extent in which a pulse 
no longer occurred (Roseweir et al., 2009). There was also a decrease in plasma 
concentrations of LH (Roseweir et al., 2009). Central infusion of p-234 during the 
peripubertal period in female rats caused delayed vaginal opening, and decreased uterine 
and ovarian weights during the expected time of puberty (Pineda et al., 2010). Chronic 
ICV administration of p-234 for 4 d prevented the subsequent LH and FSH surge during 
the time of the expected GnRH surge (Pineda et al., 2010). Systemic administration of 
labeled p-234 attenuated the acute release of LH and FSH while females were also 
administered kisspeptin-10 systemically (Pineda et al., 2010). Additionally, through the 
administration of the Kiss1-receptor antagonist p-271 there was a decrease in LH 
concentrations in OVX ewes (Smith et al., 2011). Cultures of mouse MBH explants that 
were incubated with kisspeptin in a dose dependent manner for 1 h elicited GnRH 
release, whereas this did not occur in GPR54 null animals (de Tassigny et al., 2008). 
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These data demonstrate that kisspeptin antagonists have a negative effect on reproductive 
biology and normal reproductive cyclicity.  
Kisspeptin is also important during the attainment of puberty and normal 
reproductive cyclicity in the human. One major area of concern is that in which humans 
suffer from hypogonadotrophic hypogonadism (HH). Hypogonadotrophic hypogonadism 
is characterized by a decrease in the function and release of the gonadotropins from the 
AP and a decrease in the function and weight of the gonads. Multiple studies have 
indicated that a decrease in the expression of hypothalamic of Kiss1 causes HH in the 
human and the mouse (d'Anglemont de Tassigny et al., 2007; Topaloglu et al., 2012). 
Additionally, there is also evidence that mutations in the Kiss1R and GPR54 decrease the 
effects that kisspeptins have on the hypothalamo-pituitary-gonadal axis (Semple et al., 
2005). After central and peripheral administration of kisspeptins in rats there was a dose 
dependent increase in circulating plasma levels of LH (Thompson et al., 2004). These 
data indicate that kisspeptin and GPR54 have added a new critical dimension to the 
physiological actions within the HPG axis.  
Kisspeptin restores normal reproductive cyclicity in humans and this moves one 
to believe that kisspeptin could also be used in a similar fashion in livestock species. 
Although GnRH is currently used and effectively works to cause ovulation, there may be 
other associations kisspeptin has on the hypothalamo-pituitary-gonadal axis. Not only 
may kisspeptin be used to treat animals with reproductive disorders but it could also be 
used as a diagnostic tool. Previous research has lead scientists to believe that if there are 
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decreased peripheral concentrations of kisspeptin the animal may be inferior to its 
cohorts.  
Other physiological signaling associated with kisspeptin 
 A majority of the work involving kisspeptin has focused on its interaction with 
and control of the release and regulation of GnRH. Although this has been proven to be 
true, kisspeptin is also thought to be integrated with metabolism and other hormones 
critical in the regulation of reproduction, pregnancy, and lactation. Metabolic signals and 
energy balance are important factors that influence the success of the attainment of 
puberty and reproductive cyclicity and any disruptions in such aspects may be linked to 
reproductive failure. Because the interactions between reproduction and metabolism are 
multifaceted, it is highly likely that kisspeptin plays a role in metabolic processes in the 
mammalian body. 
To date, there has been extensive research that links leptin, growth hormone, and 
IGF-I to the expression of hypothalamic Kiss1 and plasma concentrations of kisspeptin, 
however it must be stressed that a majority of these studies have used in vitro 
experiments and the in vivo experiments that have been performed have used 
pharmacological doses to elicit a response. Although precautions should be taken as to 
whether these responses occur physiologically it is plausible that some of them may and 
it is worthwhile mentioning the association of kisspeptin and metabolic factors. In 
gonadectomized ob/ob mice there was a suppression of the expression of hypothalamic 
Kiss1 when leptin was absent (Smith et al., 2006a). Also, during the re-administration of 
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leptin there was a restoration of the expression of hypothalamic Kiss1 (Smith et al., 
2006a). Central infusion of leptin in a dose dependent manner to male rats with 
uncontrolled diabetes and hypogonadotrophic hypogonadism has been shown to 
normalize the expression of hypothalamic Kiss1 (Castellano et al., 2006). It has also been 
documented that leptin administration increased the expression of ARC and POA Kiss1 
mRNA (Backholer et al., 2010). It was also demonstrated that the leptin receptor gene 
was expressed in Kiss1 neurons in the arcuate nucleus and preoptic area (Backholer et al., 
2010). These data support the notion that kisspeptin may be a modulator, through leptin 
status, of GnRH neurons and release which promotes proper function of the reproductive 
axis.  
There is a correlation between plasma levels of GH and LH, therefore it is 
plausible that there is a like between kisspeptin and GH. Cultured bovine anterior 
pituitary cells that were directly treated with kisspeptin-10 in a dose-dependent manner 
responded accordingly with a dose dependent increase in the secretion of GH (Kadokawa 
et al., 2008). Similarly, cultured rat anterior pituitary cells incubated with kisspeptin-10 
responded similarly (Gutierrez-Pascual et al., 2007). Cultured anterior pituitary cells from 
nonhuman primates also exhibited the release of GH in response to treatment of 
kisspeptin-10 (Luque et al., 2011). This evidence is suggestive of a link between 
kisspeptin and GH, however, research is equivocal. During the administration of 
kisspeptin to prepubertal cattle and prepubertal female pigs, there was no increase in 
circulating concentrations of GH (Ezzat Ahmed et al., 2009; Lents et al., 2008). Although 
research is equivocal as to whether physiological levels of kisspeptin increase the release 
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of GH, further exploration of the concept is necessary to conclude the exact mechanisms 
by which kisspeptin and GH interact.  
Another hormone that may influence kisspeptin signaling is IGF-I. Although 
insulin infusion does not appear to control the regulation of the expression of 
hypothalamic Kiss1 in diabetic rats, there are implications that IGF-I and other growth 
factors may regulate the expression of hypothalamic Kiss1 (Luque et al., 2007). In 
addition to in vivo regulation of the expression of hypothalamic Kiss1, hypothalamic cell 
cultures (N6) that were treated with insulin did not exhibit an increase in the expression 
of hypothalamic Kiss1. Hiney et al. (2009) reported that IGF-I stimulated Kiss1 gene 
expression in the hypothalamus 6 hours post administration. During that experiment it is 
also worthy of noting that plasma concentrations of E2 did not change during or after the 
infusion of IGF-I, therefore E2 did not cause the change in the expression of hypothalamic 
Kiss1 (Hiney et al., 2009). There was a marked increase in the release of LH, presumable 
through the GnRH pathway, in ovariectomized female rats that were injected with IGF-I 
or an IGF-I inhibitor during intramuscular administration of kisspeptin. (Neal-Perry et al., 
2014). Under these conditions, IGF-I also increased the kisspeptin-induced LH release 
without an increased number of GnRH immunoreactive cells (Neal-Perry et al., 2014). 
Collectively, these data indicate that there may also be a link between the IGF-I and 
kisspeptin systems in the control and regulation of the release of GnRH and LH.  
A link may exist between pregnancy and lactation specific hormones and 
kisspeptin. During intravenous kisspeptin administration to non-pregnant female rats 
plasma concentrations of oxytocin were increased (Kotani et al., 2001). During 
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pregnancy in the human there is a dramatic increase in plasma concentrations of 
kisspeptin. From baseline, there is approximately an 850-fold increase in plasma 
concentrations of kisspeptin in the first trimester and approximately a 7,000-fold increase 
in plasma concentrations of kisspeptin in the third trimester (Dhillo et al., 2007). The 
main source of the increased plasma concentrations of kisspeptin during pregnancy may 
be stemming from the placenta because the expression of Kiss1 and kisspeptin have been 
found in the syncytiotrophoblastic cells of the placenta (Horikoshi et al., 2003). The exact 
reason for the increase in kisspeptin during pregnancy is unknown and it would be 
worthwhile further investigating this concept in other species.  
Summary and Conclusion  
 Kisspeptin plays an important role in the regulation of GnRH and LH during the 
estrous cycle and attainment of puberty. It has been demonstrated that central and 
peripheral infusion of kisspeptin stimulate the release of GnRH and/or LH. In vitro, 
kisspeptin has also been shown to elicit the release of LH from anterior pituitary cells. 
During the attainment of puberty, prepubertally, and after ovariectomy, peripheral 
administration of kisspeptin-10 increased circulating plasma levels of LH in the bovine 
species. There are also implications that kisspeptin is associated with metabolic factors as 
well as pregnancy and lactation specific hormones. Although the mechanisms of 
kisspeptins actions are not fully understood and future studies may provide more insight 
into the matter, it is widely accepted that kisspeptin and the expression of hypothalamic 
Kiss1 is highly associated with hypothalamic signaling in reproductive physiology. 
Kisspeptin has been demonstrated to play a role in reproductive cyclicity throughout the 
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estrous cycle and during the attainment of puberty in the gilt, however, changes in the 
hypothalamic kisspeptin system and other related reproductive hormones have not been 
determined throughout the estrous cycle and during the peripubertal period in the gilt. 
Therefore, the objectives of the following studies was to ascertain the relationship 
between peripheral concentrations of E2 and P4, AP concentrations of kisspeptin, LH, 
and IGF-I, MBH concentrations of kisspeptin, AP expression of GnRHR and LH-, and 
MBH expression of Kiss1, Kiss1R, ER-, and ER-.  
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Chapter 2 
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM 
THROUGHOUT THE ESTROUS CYCLE IN GILTS 
 
Introduction 
 Kisspeptin administration has been found to increase serum concentrations of LH 
in a number of species. Kisspeptin has also been found to cause the release LH from AP 
cell cultures and/or cause release of AP LH in cattle (Whitlock et al., 2008), sheep 
(Sebert et al., 2010), and pigs (Lents et al., 2008); presumably through the GnRH 
pathway. Intravenous administration of kisspeptin-10 caused a 4-fold increase in plasma 
concentrations of LH within 30 minutes in the goat (Hashizume et al., 2010). Similarly in 
cattle, during intravenous and intramuscular infusion of kisspeptin-10, there was a 9.7- 
and 3-fold increase in plasma concentrations of LH, respectively (Whitlock et al., 2008). 
Pineda et al. (2010) found that there was a LH surge during ICV infusion of kisspeptin-10 
in pigs. Intravenous infusion of increasing doses of kisspeptin-10 to pre-pubertal gilts 
also stimulated an increase in LH to a similar degree (Lents et al., 2008). Therefore, these 
studies indicate that the administration of kisspeptin via ICV and intravenous infusion 
caused an increase in peripheral concentrations of LH in a number of mammalian species.  
 Anterior pituitary cell cultures from adult female baboons released LH in 
response to kisspeptin in a dose dependent manner (Luque et al., 2011). In the rat, LH 
was released in a similar fashion to that of the baboon upon kisspeptin treatment (Navarro 
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et al., 2005). The release of LH from anterior pituitary cultures has also been 
demonstrated in the horse (Decourt et al., 2008), fish (Elizur, 2009), and sheep 
(Franceschini et al., 2006).  
 Recently, research has been performed to ascertain the relationship between the 
expression of hypothalamic Kiss1 and plasma concentration of estradiol-17 (E2) 
(Oakley et al., 2009; Smith et al., 2005a). An increase in circulating concentrations E2 
caused an increase in the expression of anteroventral periventricular nucleus (AVPV) 
Kiss1 but decreased the expression of arcuate nucleus (ARC) Kiss1 in the female mouse 
(Smith et al., 2005a; Smith et al., 2006b). In the rat, the expression of AVPV Kiss1 peaks 
at a time coincident with the pre-ovulatory LH surge and Kiss1 neurons express c-Fos 
induction at a coincident time (Adachi et al., 2007; Smith et al., 2006b). Clarkson et al. 
(2008) reported that mice bearing deletions in the Kiss1R appear to lack the capacity to 
exhibit an LH surge versus mice that were ovariectomized and then treated with estrogen 
and progesterone. Hence, it is plausible that an increase in the expression of 
hypothalamic Kiss1 may contribute to the pre-ovulatory GnRH/LH surge in the pig.  
 It is widely accepted that there is a pre-ovulatory LH surge around d 19 of the 
estrous cycle in the pig (Henricks et al., 1972). Leading to the time of the pre-ovulatory 
LH surge, there is a decrease in plasma concentrations of P4 followed by an increase in 
plasma concentrations of E2 (Henricks et al., 1972). These events then lead to a standing 
estrus which occurs at a time temporally related to ovulation. Smith et al. (2009) 
demonstrated that the number of identifiable Kiss1 mRNA expressing cells and the Kiss1 
mRNA expression per cell in the pre-optic area (POA) were greater during the late 
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follicular phase versus the luteal phase in the sheep. This was also true for the number of 
identifiable Kiss1 mRNA expressing cells in the caudal and middle parts of the ARC 
(Smith et al., 2009). Smith et al. (2009) also demonstrated that there was a 2-fold increase 
in kisspeptin-immunoreactive cells in the ARC during the late-follicular phase of the 
estrous cycle versus the luteal phase of the estrous cycle. These data indicate that there is 
a link between kisspeptin and Kiss1 mRNA expression during the events that occur 
during estrus in mammals. 
 Kisspeptin has been demonstrated to play a critical role in the regulation of 
reproduction through multiple endocrine pathways, however, the changes in kisspeptin 
and related reproductive hormones throughout the estrous cycle in the gilt are yet to be 
determined. Therefore, the objective of this research was to determine serum 
concentrations of E2 and P4, anterior pituitary concentrations of LH, kisspeptin, and IGF-
I, and hypothalamic expression of Kiss1, Kiss1R, ER-, and ER- and concentrations of 
kisspeptin on various days of the porcine estrous cycle. 
Materials and Methods 
Animals 
 Forty crossbred (Duroc x Large White x Landrace) gilts of similar age (191 ± 
11.6 d) and weight (120.7 ± 32.8 kg) were used in this experiment. Gilts were penned 
(1.83 m x 2.44 m) into groups of four and received ad libitum access to a corn-soy based 
diet that contained 3.4 Mcal ME/kg, 18% protein, and 0.9% lysine and water. Each gilt 
was administered an intramuscular injection of PG600 (400 IU equine chorionic 
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gonadotropin and 200 IU human chorionic gonadotropin) two days after they were 
penned into groups of four. Twelve days after the administration of PG600 gilts were 
orally administered 15 mg of altrenogest (Matrix; Merck Animal Health, Kenilworth, NJ) 
each day and continuing for 15 d to synchronize estrus. Gilts were exposed to a mature 
boar twice daily beginning the fourth day after the cessation of the altrenogest treatment 
and continuing for 4 d to detect estrus. The first day gilts stood immobile in the presence 
of the boar was designated as d 1 of the estrous cycle.  
 Ten gilts were slaughtered at the South Dakota State University Meat Lab on days 
1, 9, 14, and 21 of the estrous cycle at which time blood samples, anterior pituitaries 
(AP), mediobasal hypothalami (MBH), and reproductive tracts were collected. Blood 
samples (10 mL) were collected from all gilts on d 1 of the estrous cycle and remaining 
gilts that had not yet been slaughtered on days 4, 7, 9, 14, 16, and 19 of the estrous cycle 
via jugular venipuncture. Blood samples were allowed to clot overnight at 4ºC then 
serum was collected by centrifugation (1,500 x g for 30 minutes at 4ºC) and stored at -
20ºC. Anterior pituitary glands and MBH were trimmed of connective tissue, bisected 
midsaggitally, wrapped in aluminum foil, snap frozen in liquid nitrogen, and stored at -
80ºC. All experimental procedures were reviewed and approved by the Institutional 
Animal Care and Use Committee at South Dakota State University.  
Estradiol-17
 Serum concentrations of E2 were determined in duplicate in all blood samples by 
RIA. Estradiol-17 (E8875; Sigma Life Science, St. Louis, MO) was the standard and 
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radioiodinated E2 (#07138228; MP Biomedicals, Solon, OH) was the tracer. Antisera 
(GDN#244 anti-estradiol-17-6-BSA; Fort Collins, CO) was used at a dilution of 
1:425,000. Sera (250-L) were extracted with a 4-mL volume of methyl tert-butyl ether. 
Recovery of [
125
I]estradiol-17 added to porcine serum before extraction averaged 96 ± 
2%. Inhibition curves of increasing amounts of sample were parallel to standard curves. 
Intra-assay and inter-assay coefficients of variation were 9.2% and 18.6%, respectively. 
Sensitivity of the assay was 0.2 pg/tube. 
Progesterone 
 Serum concentrations of progesterone were determined in duplicate in all blood 
samples by RIA. Progesterone (P0130; Sigma Life Science; St. Louis, MO) was the 
standard and radioiodinated progesterone (#07-170126; MP Biomedicals, Solon, OH) 
was used as the tracer. Antisera (#111.2C7.3; Enzo Life Sciences, Farmingdale, NY) was 
used at a dilution of 1:700,000.  Samples were diluted 1:10 prior to assay. Inhibition 
curves of increasing amounts of sample were parallel to standard curves. Intra-assay 
coefficient of variation was 12.1%. Sensitivity of the assay was 0.33 ng/tube.  
Insulin-Like Growth Factor-I 
 Anterior pituitary gland concentrations of IGF-I were determined in duplicate by 
RIA (Echternkamp et al., 1990; Funston et al., 1995). One half of each anterior pituitary 
gland was homogenized in a 15-mL polypropylene tube with 2-mL of homogenization 
buffer (1% cholic acid, 0.1% SDS, 200 M phenylmethylsulfonylfluoride, 100 M 
EDTA, 1 M leupeptin, and 1 M pepstatin) and homogenized on ice with a T25 Ultra-
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Turrax tissue dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. Anterior 
pituitary glands were then diluted to 100 mg of AP tissue/mL with homogenization 
buffer. Homogenates were centrifuged at 12,000 x g for 10 min at 4ºC and the 
supernatant was removed and stored at -20ºC. Protein content of the AP homogenates 
(1:20 dilution) was determined by the Bradford method using reagents provided by Bio-
Rad (Hercules, CA). Insulin-like growth factor binding proteins were extracted from all 
homogenized anterior pituitary gland samples with a 1:17 ratio of sample to acidified 
ethanol (12.5% 2 N HCl:87.5% absolute ethanol; (Daughaday et al., 1980)). Recombinant 
human IGF-I (GF-050; Austral Biological, San Ramon, CA) was used as the standard and 
radioiodinated antigen. Antisera (UB2-495; National Hormone and Peptide Program, 
NIDDK) was used at a dilution of 1:62,500.  Recovery of [
125
I]IGF-I added to porcine 
serum before extraction averaged 91 ±3.2%. Inhibition curves of increasing amounts of 
sample were parallel to standard curves. Intra-assay coefficient of variation was 14.8%. 
Sensitivity of the assay was 10.9 pg/tube.  
Luteinizing Hormone 
 Anterior pituitary gland concentrations of LH were determined in triplicate by 
RIA (Clapper et al., 1998). Porcine LH (AFP3881A; National Hormone and Peptide 
Program, NIDDK) was used as the radioiodinated antigen and standard. Luteinizing 
hormone antiserum (AFP15103194; National Hormone and Peptide Program, NIDDK) 
was used at a dilution of 1:200,000. Anterior pituitary homogenates were diluted 
1:25,000 in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing 
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amounts of sample were parallel to standard curves. Intra-assay coefficient of variation 
was 9.9%. Sensitivity of the assay was 0.12 ng/tube.  
Kisspeptin-54 
 Hypothalamic and AP concentrations of kisspeptin-54 were determined in 
duplicate by RIA. Human kisspeptin (1443; Tocris Bioscience, Ellsville, MO) was used 
as the radioiodinated antigen and standard. Kisspeptin antiserum (GQ2; provided by 
Waljit Dhillo, Imperial College, London, England, UK) was used at a dilution of 
1:50,000. The GQ2 kisspeptin antibody cross reacted 100% with human kisspeptin-54, 
kisspeptin-14, and kisspeptin-10 and less than 0.01% with any other related human RF 
amide protein (Dhillo et al., 2005). Hypothalami and AP homogenates were diluted 1:30 
in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing amounts of 
sample were parallel to standard curves. Inter-assay coefficients for MBH and AP assays 
were 9.4% and 11.2%, respectively. Intra-assay coefficients of variation for MBH and AP 
assays were 4.6% and 8.0%, respectively. Sensitivity of the assay was 9.68 pg/tube.  
Isolation of RNA 
 Total RNA was isolated from one half of each AP and MBH using TriReagent 
(TR118; Molecular Research Company, Cincinnati, OH). Tissue was homogenized in a 
15-mL polypropylene tube containing 1-mL of TriReagent with a T25 Ultra-Turrax tissue 
dispenser (IKA Wroks, Wilmington, NC) for 30 s at 20,500 rpm. The resulting 
homogenates were diluted to 5-mL with TriReagent. One milliliter of the homogenate 
was removed from the 15-mL polypropylene tube and pipetted into a 1.5-mL 
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polypropylene tube. One hundred microliters of 1-bromo-3-chloropropane (BCP; 
#BP151, Molecular Research Center, Cincinnati, OH) was added to the tubes containing 
1-mL of homogenate, mixed, and incubated at room temperature for 5 min. Samples were 
centrifuged (12,000 x g for 15 min at 4ºC) and the resulting aqueous layer was removed. 
Isopropanol (500 L) was added to the aqueous layer to precipitate the RNA. The 
resulting RNA pellet was washed twice with 75% ethanol, centrifuged, dried, and 
suspended in nuclease-free water. Concentration of RNA was determined via 
spectrophotometer (Nanodrop, Thermo Scientific, Washington, DE). Purity of RNA was 
determined by measuring the A260/A280 ratio. The ratio of all samples ranged from 1.8 to 
2.0.  
cDNA Synthesis 
 Any contaminating DNA was removed from 10 g of AP RNA and 5 g of MBH 
RNA for each sample using the Turbo DNA-Free™ Kit (#AM1907; Ambion, Austin, 
TX) following the manufacturer’s protocol. Two micrograms of the resulting RNA was 
reverse transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit 
containing random hexamer primers (#4374966; Applied Biosystems, Foster City, CA) 
following the manufacturer’s protocol.  
Porcine Primers 
 Previously published mRNA sequences for the gene of interest and porcine -
actin were used to design specific forward and reverse primers. Primers were designed 
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using software provided by Integrated DNA Technologies (IDT, Coralville, IA; Table 
2.1).  
Real-Time PCR 
 Real-time semi-quantitative PCR was used to measure the quantity of MBH ER-
, ER-, Kiss1, and Kiss1R, and AP LH- mRNA relative to the amount of porcine -
actin mRNA in each sample. Measurements of the relative quantity of the cDNA of 
interest was carried out using RT
2
 Real-Time™ SYBR Green/ROX PCR Master Mix 
(SuperArray Bioscience Corp., Foster City, CA). Twenty-five microliter reactions were 
measured using the Stratagene MX3005P quantitative real-time PCR instrument (Agilent 
Technologies, Foster City, CA). Thermal cycling conditions recommended by the 
manufacturer (40 cycles of 30 sec at 95ºC, 1 min at 55ºC, and 1 min at 72ºC) were used 
for all genes except Kiss1, in which the following thermal cycling conditions were used; 
45 cycles of 30 sec at 95ºC, 1 min and 3 sec at 55ºC, and 1 min at 72ºC. Concentrations 
of forward and reverse primers used for the genes of interest were 300 nM, except 
Kiss1R, in which concentrations of forward and reverse primers were used at a 
concentration of 800 nM. A linear response was obtained when these concentrations of 
primer pairs were used with increasing amounts of cDNA. Dissociation curve analysis 
was performed after each real-time PCR run to confirm that a single amplicon of 
appropriate melting temperature was present. Additionally, all amplicons were 
electrophoresed through a 2% agarose gel and stained with ethidium bromide to visualize 
that only amplicons of the appropriate size were present in each sample.  
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Table 2.1 
Forward and reverse primers for Real-Time PCR for porcine mRNA 
Gene and                    Primer                                                                      Amplicon Size 
Accession Number 
pKiss1 
(NM_001134964.1)
a
        89 bp 
       Forward    5’ – GGCAGCTGATGTTCTTTCTTTG – 3’ 
       Reverse     5’ – CGGGCCTGTAGATCTAGGATT – 3’ 
pKiss1R 
(NM_001044624.2)
b
        110 bp 
       Forward     5’ – CAGGGAACTCACTTGTCATCTT – 3’ 
       Reverse    5’ – GCACAGCAGAAACGTCAAATC – 3’ 
pER-

c
        124 bp 
       Forward     5’ – GGACAGGGATGAAGGGAAATG – 3’ 
       Reverse     5’ – CATGGCCTTGACACAGAGATAC – 3’    
pER- 
(NM_214220)
d
         91 bp 
       Forward     5’ – GAATGTTGAAGCACAAGCGCCAGA – 3’ 
       Reverse     5’ – ACCGGGCTGTTCTTCTTAGTGTGT – 3’ 
pLH- 
(NM_214080.1)
e
        151 bp 
       Forward     5’ – ATGCTCCAGAGACTGCTGTTGT – 3’ 
       Reverse     5’ – TGCTGGTGGTAAAGGTGATGCAGA – 3' 
p-actin 
(U07786.1)
f
         129 bp 
       Forward     5’ – TCGCCGACAGGATGCAGAAGGA – 3’ 
       Reverse     5’ – AGGTGGACAGCGAGGCCAGGAT – 3’  
a 
porcine Kiss1; 
b
 porcine Kiss type 1 receptor; 
c
 porcine estrogen receptor-beta; 
d
 porcine 
estrogen receptor-alpha; 
e
 porcine luteinizing hormone subunit beta; 
f
 porcine beta-actin  
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Statistical Analysis 
 To determine the effect of day of the estrous cycle on serum concentrations of 
estradiol-17and progesterone, hypothalamic concentrations of kisspeptin-54, and 
anterior pituitary concentrations of kisspeptin-54, IGF-I and LH, statistical analyses were 
performed using the Mixed Procedure of SAS 9.3 (SAS 9.3, SAS). The model for 
determining differences in serum concentrations of estradiol-17 and progesterone was 
Yijkl =  + Pigi + Treatmentj + Pigi(Treatment)j + Dayk + Treatmentj x Dayk 
+Pigi(Treatment)j x Dayk + eijkl with repeated measures. The model for determining 
differences in hypothalamic concentrations of kisspeptin-54, and anterior pituitary 
concentrations of kisspeptin-54, IGF-I, and LH was Yijkl =  + Pigi + Treatmentj + 
Pigi(Treatment)j + Dayk + Treatmentj x Dayk +Pigi(Treatment)j x Dayk + eijkl. Pig within 
treatment by day was the subplot error term used to test pig, day, and treatment by day 
effects.  
 Fold differences in expression of MBH Kiss1, Kiss1R, ER-, and ER- and AP 
LH- among treatments was determined using the Relative Expression Software Tool 
(REST; Corbett Research & M. Pfaffl, Technical University Munich). The expression of 
a target gene is standardized by a non-regulated gene. Relative expression is based on the 
expression ratio of a target gene versus a reference gene. The expression ratio results of 
the investigated transcripts were tested for significance by Pair Wise Fixed Reallocation 
Randomized Test (Pfaffl et al., 2002). 
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Results 
Mean serum concentrations of E2 were greatest (P<0.05) on d 19 of the estrous 
cycle and were not different (P>0.05) on days 4, 7, 9, and 14 of the estrous cycle (Figure 
2.1). On d 1 of the estrous cycle, mean serum concentrations of estradiol-17 were 
greater (P<0.05) than on days 4 and 21 of the estrous cycle (Figure 2.1). Mean serum 
concentrations of estradiol-17 were greater (P<0.05) on d 16 compared to d 21 of the 
estrous cycle (Figure 2.1).  
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Figure 2.1. Mean serum concentrations of estradiol-17in gilts throughout various days 
of the estrous cycle. Means are expressed as least square means ± SEM. 
abcd
Means with 
different letters differ (P<0.05) by day.  
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Mean serum concentrations of progesterone followed the typical pattern observed 
throughout the estrous cycle in gilts (Figure 2.2). Mean serum concentrations of P4 
increased from d 1 through 14 and were greatest (P<0.05) at d 14 of the estrous cycle 
(Figure 2.2). From d 14 to d 21 of the estrous cycle mean serum concentrations of P4 
decreased (P<0.05) (Figure 2.2).  
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Figure 2.2. Mean serum concentrations of progesterone in gilts throughout various days 
of the estrous cycle. Means are expressed as least-square means ± SEM. 
abcdef
Means with 
different letters differ (P<0.05) by day.  
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 Mean AP concentrations of IGF-I were greater (P<0.05) on d 21 compared to d 1 
of the estrous cycle (Figure 2.3). No other differences among days of the estrous cycle 
were detected (P>0.05) (Figure 2.3).  
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Figure 2.3. Mean AP concentrations of IGF-I in gilts (n=10/d) on d 1, 9, 14, and 21 of 
the estrous cycle. Data are expressed as least-square means ± SEM. 
ab
Means with 
different letters differ (P<0.05) by day. 
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Mean AP concentrations of LH were greatest (P<0.05) on day 14 of the estrous 
cycle (Figure 2.4). Mean AP concentrations of LH were not different (P>0.05) on days 1 
and 9, and 1 and 21 of the estrous cycle (Figure 2.4), however mean AP concentrations of 
LH were greater (P<0.05) on day 9 versus 21 of the estrous cycle (Figure 2.4).  
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Figure 2.4. Mean AP concentrations of LH in gilts (n=10/d) on d 1, 9, 14, and 21 of the 
estrous cycle. Data are expressed as least-square means ± SEM. 
abc
Means with different 
letters differ (P<0.05) by day. 
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No differences were detected (P>0.05) in mean AP concentrations of kisspeptin 
throughout the estrous cycle (Figure 2.5).  
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Figure 2.5. Mean AP concentrations of kisspeptin in gilts (n=10/d) on d 1, 9, 14, and 21 
of the estrous cycle. Data are expressed as least-square means ± SEM. 
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No differences were detected (P>0.05) in mean MBH concentrations of kisspeptin 
throughout the estrous cycle (Figure 2.6). 
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Figure 2.6. Mean MBH concentrations of kisspeptin in gilts (n=10/d) on d 1, 9, 14, and 
21 of the estrous cycle. Data are expressed as least-square means ± SEM. 
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 Mean relative expression of MBH ER- did not differ (P>0.05) in gilts 
throughout the estrous cycle (Figure 2.7). 
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Figure 2.7. Mean relative expression of MBH ER- in gilts (n=10/d) on days 1, 9, 14, 
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of 
ER-by semi-quantitative real-time reverse transcriptase PCR with normalization for the 
corresponding level of -actin. Data are expressed as a fold change in expression relative 
to the values in pigs on d 1 of the estrous cycle. 
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 Mean relative expression of MBH ER-was up-regulated (P<0.05) on days 9 and 
14 compared to day 21 of the estrous cycle (Figure 2.8).  
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Figure 2.8. Mean relative expression of MBH ER- in gilts (n=10/d) on days 1, 9, 14, 
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of 
ER-by semi-quantitative real-time reverse transcriptase PCR with normalization for the 
corresponding level of -actin. Data are expressed as a fold change in expression relative 
to the values in pigs on d 1 of the estrous cycle. 
abc
Means with different letters differ 
(P<0.05) as determined by the relative expression software tool. 
 
 
 
 
 
 
 
 
  41 
 
 Mean relative expression of MBH Kiss1 was greatest (P<0.05) on d 21 of the 
estrous cycle (Figure 2.9). Mean relative expression of MBH Kiss1 was down-regulated 
(P<0.05) on days 1 versus 14 and 21 and 9 versus 21 of the estrous cycle (Figure 2.9).  
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Figure 2.9. Mean relative expression of MBH Kiss1 in gilts (n=10/d) on days 1, 9, 14, 
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of 
Kiss1by semi-quantitative real-time reverse transcriptase PCR with normalization for the 
corresponding level of -actin. Data are expressed as a fold change in expression relative 
to the values in pigs on d 1 of the estrous cycle. 
abc
Means with different letters differ 
(P<0.05) as determined by the relative expression software tool. 
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 Mean relative expression of MBH Kiss1R did not differ (P>0.05) in gilts 
throughout the estrous cycle (Figure 2.10). 
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Figure 2.10. Mean relative expression of MBH Kiss1R in gilts (n=10/d) on days 1, 9, 14, 
and 21 of the estrous cycle. Total RNA was DNase treated and analyzed for the level of 
Kiss1Rby semi-quantitative real-time reverse transcriptase PCR with normalization for 
the corresponding level of -actin. Data are expressed as a fold change in expression 
relative to the values on d 1. 
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Discussion 
 Kisspeptin, a protein produced by most mammalian species, has been found in 
many tissues in the body (Li et al., 2008). Kisspeptins are small, neurohormones encoded 
by the Kiss1 gene (Kotani et al., 2001).  After ICV and intra-ARC infusion of kisspeptin 
antibodies there was a profound decrease in serum concentrations of LH in the rat (Li et 
al., 2009). Kisspeptin has been shown to elicit the release of LH via ICV, intramuscular, 
and intravenous infusion in a number of mammalian species (Lents et al., 2008; Sebert et 
al., 2010; Whitlock et al., 2008). Kisspeptin-54 has also been demonstrated to stimulate 
the hypothalamo-pituitary gonadal axis in humans (Chan et al., 2012; Dhillo et al., 2005). 
Although these studies demonstrated that exogenous kisspeptin can cause the release of 
LH, it is also thought that endogenous kisspeptin released by the hypothalamus of 
mammals can cause the release of LH.  
 In the present study, estradiol-17 and progesterone followed patterns that were 
indicative of a normal porcine estrous cycle. Henricks et al. (1972) demonstrated that 
during the luteal phase (from d 4 to 16 of the estrous cycle) plasma concentrations of 
estrogen were low (< 20 pg/mL/animal). Following that, plasma concentrations of 
estrogen started to increase and reached their peak (> 50 pg/mL/animal) between 1 and 2 
days before estrus (Henricks et al., 1972). Mean plasma concentrations of progesterone 
increased dramatically from d 2 to 6 of the estrous cycle and continued until they peaked 
by d 12 of the estrous cycle (Henricks et al., 1972). In the present study, serum 
concentrations of estrogen started to increase only after plasma concentrations of 
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progesterone started to decrease, which was temporally related with the next expected LH 
surge.  
 Insulin-like growth factor-I has been shown to positively associate with estrogen, 
in that E2 caused an increase in peripheral and AP concentrations of IGF-I in the pig 
(Hilleson-Gayne and Clapper, 2005; Rempel and Clapper, 2002). Estrogens are 
synthesized from androgens via aromatase enzymes (Simpson et al., 1994). Anastrozole 
is a non-steroidal aromatase-inhibiting compound that has been shown to dramatically 
reduce the synthesis of estrogens and reduce plasma concentrations of estrogen by 86% 
in women (Geisler et al., 2001; Mauras et al., 2000). Hilleson-Gayne and Clapper (2005) 
demonstrated that serum concentrations of IGF-I were greater in boars that were 
untreated versus boars that were treated with anastrozole. Estrogen has also been 
demonstrated to affect concentrations of AP IGF-I in the pig as well. Rempel and Clapper 
(2002) reported that estrogen implanted barrows had greater AP concentrations of IGF-I 
versus untreated barrows and boars. These data support the notion that E2 could also 
affect the AP concentrations of IGF-I during various days of the estrous cycle. Gilts 
slaughtered on the last day of the estrous cycle and at a time directly following greater 
serum concentrations of E2 (day 19) had greater AP concentrations of IGF-I versus gilts 
that had lesser serum concentrations of E2 directly following a standing estrus on d 1 of 
the experiment. Insulin-like growth factor-I has been demonstrated to stimulate the 
release of LH from cultured AP cells in rats and pigs (Soldani et al., 1994; Whitley et al., 
1995). Adam et al. (1998) also demonstrated that peripheral administration of IGF-I can 
acutely stimulate an increased in plasma concentrations of LH in sheep. Therefore, it is 
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plausible that IGF-I may affect the AP LH system and work in concert with kisspeptin to 
cause a greater release of LH.  
 Mean AP concentrations of LH were greatest on d 14 of the estrous cycle and 
least on d 1 and 21; a time coincident with a standing estrus and a time temporally related 
with the next expected estrus, respectively. These data coincide with the patterns of E2 
and P4. Henricks et al. (1972) demonstrated that serum concentrations of LH decreased 
after a standing estrus until just before the subsequent estrus when LH increased to its 
peak. During the peak in LH, serum concentrations of estrogen were increased and serum 
concentrations of progesterone remained decreased (Henricks et al., 1972). Additionally, 
Baird and Scaramuzzi (1976) found that basal peripheral concentrations of LH decreased 
to a level similar to peripheral concentrations of LH during the luteal phase of the estrous 
cycle following subcutaneous P4 implantation in ewes. In the present study, it is plausible 
that increased P4, in the face of decreased E2, was providing negative feedback to the 
MBH and AP during the luteal phase of the estrous cycle causing a buildup of AP LH 
prior to the pre-ovulatory LH surge.  
 Past research has shown that there is a correlation between circulating 
concentrations of sex steroids and hypothalamic concentrations of kisspeptins and 
expression of Kiss1 (Kauffman et al., 2007; Smith et al., 2005a; Smith et al., 2005b). In 
the present study, there was no difference in MBH and AP concentrations of kisspeptin-
54 throughout various days of the estrous cycle, however there was an increase in relative 
MBH Kiss1 gene expression versus the first day of the estrous cycle compared to the last 
day of the estrous cycle. Increased relative MBH Kiss1 gene expression occurred at a 
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time coincident with greater serum concentrations of E2 and greater AP concentrations of 
LH. Cui et al. (2015) performed an experiment measuring Kiss1 and GnRH gene 
expression and protein concentration in multiple areas of the hypothalamus in 
ovariectomized (OVX) and rats treated with E2. During the onset of puberty, kisspeptin-
immunoreactive cells increased in the ARC, periventricular nucleus, and preoptic areas 
(Cui et al., 2015). Levels of both hypothalamic Kiss1 and GnRH gene expression were 
greater in OVX + E2 and/or intact + E2 compared to OVX and intact animals that were 
not treated with E2 (Cui et al., 2015). Furthermore, hypothalamic expression of Kiss1 
mRNA during estrus was decreased versus other stages of the estrous cycle in the rat 
(Salehi et al., 2013). These data support the notion that an increase in hypothalamic Kiss1 
mRNA and hypothalamic kisspeptin concentration play a role in modulating the activity 
of estrogen during the time an animal expresses estrus. Though the timing of sample 
collection impacts the outcome greatly, the present study parallels with past research. 
During expression of estrus, when serum concentrations of E2 were greater, there was a 
decrease in hypothalamic expression of Kiss1 compared to the last day of the estrous 
cycle when serum concentrations of E2 were lesser.  
 Kisspeptins bind to their cognate receptor, GPR54, with high affinity (Messager 
et al., 2005). There is evidence that GnRH neurons possess kisspeptin receptors and after 
kisspeptin binds to GPR54 there is an increase in hypothalamic concentrations of GnRH 
(Messager et al., 2005). The Kiss1R gene has been demonstrated to be highly abundant in 
multiple tissues in the body, including the hypothalamus and anterior pituitary gland (Li 
et al., 2008). In the present study, hypothalamic Kiss1R gene expression was measured 
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on various days of the estrous cycle but no differences among days were found. Kisney-
Jones et al. (Kinsey-Jones et al., 2009) reported that there was a down-regulation of 
hypothalamic expression of Kiss1R during a stress-induced suppression of LH in the 
female rat. Although there were no differences among days of the estrous cycle it is 
plausible that variations in the expression of the Kiss1R gene and the number of 
kisspeptin receptors may influence the GnRH pathway and endocrine status of the animal 
at a time coincident with a standing estrus. 
 No differences were detected in mean relative expression of MBH ER-, however 
mean relative expression of MBH ER- was decreased on d 21 of the estrous cycle 
compared to d 9 and 14 of the estrous cycle and tended to be lesser on d 21 compared to d 
1 of the estrous cycle. In the rat, selective blockade of ER- in gonadally intact, cyclic 
females decreased the release of LH in response to kisspeptin, inhibited the preovulatory 
LH surge, and blocked ovulation (Roa et al., 2008). Roa et al. (2008) also demonstrated 
that after selective activation of ER- there was an increase in LH secretion in response 
to kisspeptin. This was not the case when ER- was activated (Roa et al., 2008). 
Additionally, when rats were treated with an ER- antagonist the preovulatory LH surge 
still occurred, however there was a decrease in acute LH responses to kisspeptin (Roa et 
al., 2008). Although there are alterations in the MBH expression of ER- and ER-in the 
present study, GnRH neurons may not be direct targets for the actions of E2 (Herbison 
and Theodosis, 1992; Shivers et al., 1983).  Kisspeptin is a potent secretagogue of GnRH 
(Dhillo et al., 2005; Gottsch et al., 2004). Additionally, kisspeptin possess estrogen 
receptors (Franceschini et al., 2006; Smith et al., 2005a; Smith et al., 2006b), and AVPV 
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expression of Kiss1 is up-regulated at a time coincident with the LH surge (Adachi et al., 
2007; Smith et al., 2006b). Therefore, the hypothalamic kisspeptin system and ER- and 
– are closely integrated and alterations in hypothalamic expression of ER- and – may 
cause increased release of kisspeptin, the subsequent GnRH/LH surge, and the attainment 
of puberty in mammalian species.  
 In conclusion, kisspeptin has been demonstrated to cause the release of LH in vivo 
and in vitro in a number of mammalian species, including the gilt (Lents et al., 2008; 
Sebert et al., 2010; Whitlock et al., 2008). Recent research has also described the 
relationship between increased peripheral concentrations of E2 and increased 
hypothalamic concentrations of Kiss1 (Oakley et al., 2009; Smith et al., 2005a; Smith et 
al., 2006b). In the present study, there were variations in hypothalamic Kiss1 gene 
expression at key time points in the estrous cycle; particularly just before gilts expressed 
estrus. Kisspeptin may be an important hormone driving normal reproductive cyclicity, 
however the timing at which samples are collected is critical and needs to be further 
investigated.  
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Chapter 3 
EVALUATION OF THE HYPOTHALAMIC KISSPEPTIN SYSTEM DURING 
THE ATTAINMENT OF PUBERTY IN GILTS 
 
Introduction 
 Activation of gonadotropin releasing hormone (GnRH) neurons and the release of 
GnRH is critical for the attainment of puberty, however, research is equivocal as to 
whether GnRH neurons lack estrogen receptors. Therefore other endocrine pathways that 
are plausible to cause the preovulatory luteinizing hormone (LH) surge are of interest. 
Several researchers have hypothesized that kisspeptin works at the level of the 
hypothalamus to activate GnRH neurons and start the onset of puberty. Through the 
administration of exogenous kisspeptin it has been shown that kisspeptin increased 
hypothalamic concentrations of GnRH at puberty in a number of species including 
primates (Skorupskaite et al., 2014), rodents (Messager et al., 2005), and sheep (Li et al., 
2012). Central administration of kisspeptin increased plasma concentrations of LH in 
prepubertal female rats versus controls (Navarro et al., 2004). Repetitive administration 
of kisspeptin to prepubertal female lambs increased plasma concentrations of sex steroids 
and caused a LH surge (Redmond et al., 2011). Therefore, kisspeptin has been found to 
increase hypothalamic concentrations of GnRH and plasma concentrations of LH during 
the attainment of puberty in multiple mammalian species.  
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 The expression of hypothalamic Kiss1 is associated with the attainment of 
puberty in mammalian species. Navarro et al. (2004) reported that immediately before the 
onset of puberty there was a dramatic increase in the expression of hypothalamic Kiss1 in 
female and male rats. This same phenomenon has been reported in gonadally intact 
female monkeys (Shahab et al., 2005). It was also shown that hypothalamic Kiss1 mRNA 
expression was up regulated in ovariectomized (OVX) and intact rats that were 
administered E2 compared to OVX and intact rats that received no estradiol-17 (E2) (Cui 
et al., 2015). Navarro et al. (2004) showed that there was an increase in hypothalamic 
expression of Kiss1 around the time of puberty in male and female rats. Similarly, there 
was also an increase in the MBH expression of Kiss1 mRNA during the attainment of 
puberty in intact female rhesus monkeys (Shahab et al., 2005). Nestor et al. (2012) also 
showed that the number of kisspeptin neurons in the ARC was greater in post-pubertal 
ewes versus pre-pubertal lambs. Therefore, it is evident that an increase in hypothalamic 
Kiss1 gene expression is correlated with hypothalamic concentrations of kisspeptin and 
an increase in the production of GnRH at a time coincident with the attainment of puberty 
in mammals. 
 It is widely accepted that exogenous and endogenous kisspeptin partially control 
the LH surge (Lents et al., 2008; Luque et al., 2011). A multitude of research has also 
been done demonstrating the effects of the administration of a kisspeptin antagonist and 
its effects on the hypothalamo-pituitary-gonadal axis. During ICV infusion of a 
kisspeptin antagonist in the ewe there was no pulsatile release of LH detected compared 
to controls (Roseweir et al., 2009). Smith et al. (2011) demonstrated that through the 
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administration of a Kiss1-receptor antagonist there was a decrease in plasma 
concentrations of LH in OVX ewes. Intracerebroventricular infusion of a kisspeptin 
antagonist also caused delayed vaginal opening, decreased uterine and ovarian weights, 
and prevented the LH and FSH surge in female rats (Pineda et al., 2010). Hence, through 
the administration of kisspeptin antagonists, it has been proven that kisspeptin is a pivotal 
hormone that causes the release of LH in sheep, rats, and pigs (Lents et al., 2008).  
 Kisspeptin has been proven essential in puberty through its intimate relationship 
with GnRH neurons (Hrabovszky et al., 2007). Measurement of hypothalamic Kiss1 
mRNA expression and hypothalamic concentrations of kisspeptin along with other 
hormones may provide insight into possible answers regarding kisspeptins exact 
association with the attainment of puberty. Previous research has shown that kisspeptin 
plays an integral role in the regulation of reproduction, however, changes in the 
hypothalamic kisspeptin system and related reproductive hormones during the 
peripubertal period in gilts has not been determined. Therefore, the objectives of the 
current experiments were to determine 1) plasma concentrations of E2 and P4, 2) AP 
concentrations of LH, IGF-I and kisspeptin, and 3) MBH expression of Kiss1 and 
concentrations of kisspeptin during the peripubertal period in the gilt. 
Materials and Methods 
Animals 
 Two experiments were conducted with twenty five crossbred gilts (Duroc x Large 
White x Landrace) in each experiment. On d 1 of both experiments, gilts were received 
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and penned (1.83 x 2.44 m) into groups of 3 and 4. Gilts were of similar age (151.5 ± 4.5 
d) and weight (104.9 ± 0.3 kg) in both experiments. Gilts were given ad libitum access to 
water and a corn-soy based diet that contained 3.4 Mcal ME/kg, 18% protein, and 0.9% 
lysine. On day 1 of both experiments gilts were exposed to a mature boar twice daily. 
Gilts were exposed to a mature boar for 6 d in the first experiment and 7 d in the second 
experiment. Gilts in the first experiment were slaughtered on d 7 and gilts in the second 
experiment were slaughtered on d 8. In the first experiment, blood samples (10 mL) were 
collected from gilts via jugular venipuncture on d 1 and 3 into sodium heparin tubes. In 
the second experiment, blood samples (10 mL) were collected from gilts via jugular 
venipuncture on d 2, 4, and 6 into sodium heparin tubes. All samples were collected on 
ice, centrifuged (1,500 x g, for 30 min at 4ºC), and frozen within 60 min to prevent 
protein degradation.  
Estrus detection was performed twice daily at 12 h intervals in both experiments. 
The day gilts stood immobile in the presence of the boar was considered the day they 
attained puberty (n=8/study). The remaining gilts (n=17/study) that did not stand in estrus 
within 24 hours of slaughter were considered to be peripubertal. On d 7 of the first 
experiment and d 8 of the second experiment all gilts were slaughtered at the South 
Dakota State University Meat Lab when blood, anterior pituitaries (AP), mediobasal 
hypothalami (MBH), and reproductive tracts were collected. Anterior pituitary glands and 
MBH were trimmed of connective tissue, bisected midsaggitally, wrapped in aluminum 
foil, snap frozen in liquid nitrogen, and stored at -80ºC. Following slaughter, reproductive 
tracts were subjectively evaluated for edema and tone and ovaries were evaluated for 
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structures including follicles, corpora hemmorhagica, corpora lutea, and corpora 
albicantia to determine if gilts had cycled prior to the experiment. All experimental 
procedures were reviewed and approved by the Institutional Animal Care and Use 
Committee at South Dakota State University.   
Estradiol-17
 For both experiments plasma concentrations of E2 were determined in duplicate 
by RIA in the same assay. Estradiol-17 (E8875; Sigma Life Science, St. Louis, MO) 
was the standard and radioiodinated E2 (#07138228; MP Biomedicals, Solon, OH) was 
the tracer. Antisera (GDN#244 anti-estradiol-17-6-BSA; Fort Collins, CO) was used at 
a dilution of 1:425,000. Sera (250-L) were extracted with a 4-mL volume of methyl tert-
butyl ether. Recovery of [
125
I]estradiol-17 added to porcine plasma before extraction 
averaged 94.6 ± 2.5%. Inhibition curves of increasing amounts of sample were parallel to 
standard curves. Intra-assay and inter-assay coefficients of variation were 11.4% and 
15.7%, respectively. Sensitivity of the assay was 0.5 pg/tube.  
Insulin-Like Growth Factor I 
 Anterior pituitary gland concentrations of IGF-I were determined in duplicate by 
RIA (Echternkamp et al., 1990; Funston et al., 1995). One half of each anterior pituitary 
gland was homogenized in a 15-mL polypropylene tube with 2-mL of homogenization 
buffer (1% cholic acid, 0.1% SDS, 200 M phenylmethylsulfonylfluoride, 100 M 
EDTA, 1 M leupeptin, and 1 M pepstatin) and homogenized on ice with a T25 Ultra-
Turrax tissue dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. Anterior 
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pituitary glands were then diluted to 100 mg of AP tissue/mL with homogenization 
buffer. Homogenates were centrifuged at 12,000 x g for 10 min at 4ºC and the 
supernatant was removed and stored at -20ºC. Protein content of the AP homogenates 
(1:20 dilution) was determined by the Bradford method using reagents provided by Bio-
Rad (Hercules, CA). Insulin-like growth factor binding proteins were extracted from all 
homogenized anterior pituitary gland samples with a 1:17 ratio of sample to acidified 
ethanol (12.5% 2 N HCl:87.5% absolute ethanol; (Daughaday et al., 1980)). Recombinant 
human IGF-I (GF-050; Austral Biological, San Ramon, CA) was used as the standard and 
radioiodinated antigen. Antisera (UB2-495; National Hormone and Peptide Program, 
NIDDK) was used at a dilution of 1:62,500. Recovery of [
125
I]IGF-I added to porcine 
serum before extraction averaged 83 ± 1.5%. Inhibition curves of increasing amounts of 
sample were parallel to standard curves. Intra-assay coefficient of variation in the first 
experiment was 14.8%. Intra-assay and inter-assay coefficients of variation in the second 
experiment were 3.2% and 7.9%, respectively. Sensitivity of the assay for both 
experiments was 11.9 pg/tube. 
Luteinizing Hormone 
 Anterior pituitary gland concentrations of LH were determined in triplicate by 
RIA (Clapper et al., 1998). Porcine LH (AFP3881A; National Hormone and Peptide 
Program, NIDDK) was used as the radioiodinated antigen and standard. Luteinizing 
hormone antiserum (AFP15103194; National Hormone and Peptide Program, NIDDK) 
was used at a dilution of 1:200,000. Anterior pituitary homogenates were diluted 
1:25,000 in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing 
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amounts of sample were parallel to standard curves. Intra-assay coefficient of variation in 
the first experiment was less than 1%. Intra-assay and inter-assay coefficients of variation 
in the second experiment were 16.5% and 15.8%, respectively. Sensitivity of the assay 
for both experiments was 0.10 ng/tube. 
Kisspeptin-54 
 Hypothalamic and AP concentrations of kisspeptin-54 were determined in 
duplicate by RIA. Human kisspeptin (1443; Tocris Bioscience, Ellsville, MO) was used 
as the radioiodinated antigen and standard. Kisspeptin antiserum (GQ2; provided by 
Waljit Dhillo, Imperial College, London, England, UK) was used at a dilution of 
1:50,000. The GQ2 kisspeptin antibody cross reacted 100% with human kisspeptin-54, 
kisspeptin-14, and kisspeptin-10 and less than 0.01% with any other related human RF 
amide protein (Dhillo et al., 2005). Hypothalami and AP homogenates were diluted 1:30 
in 0.01 M PBS-0.1% gelatin prior to assay. Inhibition curves of increasing amounts of 
sample were parallel to standard curves. Intra-assay coefficients of variation for MBH 
and AP assays for the first experiment were 4.6% and 8.0%, respectively. Intra-assay 
coefficient of variation for all samples of the second experiment was 7.2%. Sensitivity of 
the assay for both experiments was 10.1 pg/tube.  
Isolation of RNA 
 Total RNA was isolated from one half of each AP and MBH using TriReagent 
(TR118; Molecular Research Company, Cincinnati, OH). Tissue was homogenized in a 
15-mL polypropylene tube containing 1-mL of TriReagent with a T25 Ultra-Turrax tissue 
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dispenser (IKA Works, Wilmington, NC) for 30 s at 20,500 rpm. After homogenization 
the resulting homogenates were diluted to 5-mL with TriReagent. One milliliter of the 
resulting homogenate was removed from the 15-mL polypropylene tube and pipetted into 
a 1.5-mL polypropylene tube. One hundred microliters of 1-bromo-3-chloropropane 
(BCP; #BP151, Molecular Research Center, Cincinnati, OH) was added to the 
polypropylene Eppendorf tubes containing 1-mL of homogenate, mixed, and incubated at 
room temperature for 5 min. Samples were centrifuged (12,000 x g for 15 min at 4ºC) 
and the resulting aqueous layer was removed. Isopropanol (500 L) was added to the 
aqueous layer to precipitate the RNA. The resulting RNA pellet was washed twice with 
75% ethanol, centrifuged, dried, and suspended in nuclease-free water. Concentration of 
RNA was determined via spectrophotometer (Nanodrop, Thermo Scientific, Washington, 
DE). Purity of RNA was determined by measuring the A260/A280 ratio. The ratio of all 
samples ranged from 1.8 to 2.0.  
cDNA Synthesis 
 Any contaminating DNA was removed from 10 g of AP RNA and 5 g of MBH 
RNA for each sample using the Turbo DNA-Free™ Kit (#AM1907; Ambion, Austin, 
TX) following the manufacturer’s protocol. Two g of the resulting RNA was reverse 
transcribed into cDNA using the High-Capacity cDNA Reverse Transcription Kit 
containing random hexamer primers (#4374966; Applied Biosystems, Foster City, CA) 
following the manufacturer’s protocol. 
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Porcine Primers 
 Previously published mRNA sequences for the gene of interest, porcine -actin, 
was used to design specific forward and reverse primers. Primers were designed using 
software provided by Integrated DNA Technologies (IDT, Coralville, IA; Table 3.1). 
Real-Time PCR 
 Real-time semi-quantitative PCR was used to measure the quantity of MBH Kiss1 
and Kiss1R and AP LH- and gonadotropin releasing hormone receptor (GnRHr) mRNA 
relative to the amount of -actin mRNA in each sample. Measurements of the relative 
quantity of the cDNA of interest was carried out using RT
2
 Real-Time™ SYBR 
Green/ROX PCR Master Mix (SuperArray Bioscience Corp., Foster City, CA). Twenty-
five microliter reactions were measured using the Stratagene MX3005P quantitative real-
time PCR instrument (Agilent Technologies, Foster City, CA). Thermal cycling 
conditions recommended by the manufacturer (40 cycles of 30 sec at 95ºC, 1 min at 
55ºC, and 1 min at 72ºC) were used for all except Kiss1, in which the following thermal 
cycling conditions were used; 45 cycles of 30 sec at 95ºC, 1 min and 3 sec at 55ºC, and 1 
min at 72ºC. Concentrations of forward and reverse primers used for the genes of interest 
were 300 nM, except Kiss1R, in which concentrations of forward and reverse primers 
were used at a concentration of 800 nM. A linear response was obtained when these 
concentrations of primer pairs were used with increasing amounts of cDNA. Dissociation 
curve analysis was performed after each real-time PCR run to confirm that a single 
amplicon of appropriate melting temperature was present. Additionally, all amplicons 
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were electrophoresed through a 2% agarose gel and stained with ethidium bromide to 
visualize that only amplicons of the appropriate size were present in each sample. 
 
Table 3.1. 
Forward and reverse primers for Real-Time PCR for porcine mRNA 
Gene and                    Primer                                                                      Amplicon Size 
Accession Number 
pKiss1 
(NM_001134964.1)
a
        89 bp 
       Forward    5’ – GGCAGCTGATGTTCTTTCTTTG – 3’ 
       Reverse     5’ – CGGGCCTGTAGATCTAGGATT – 3’ 
pLH- 
(NM_214080.1)
c
        151 bp 
       Forward     5’ – ATGCTCCAGAGACTGCTGTTGT – 3’ 
       Reverse     5’ – TGCTGGTGGTAAAGGTGATGCAGA – 3' 
GnRHR 
(NM_214273.1)
d
        101 bp 
       Forward     5’ – AGCCAACCTGTTGGAGACTCTGAT – 3’ 
       Reverse     5’ – AGCTGAGGACTTTGCAGAGGAACT – 3' 
p-actin 
(U07786.1)
e
         129 bp 
       Forward     5’ – TCGCCGACAGGATGCAGAAGGA – 3’ 
       Reverse     5’ – AGGTGGACAGCGAGGCCAGGAT – 3’  
a 
porcine Kiss1; 
b
 porcine Kiss type 1 receptor; 
c
 porcine luteinizing hormone subunit beta; 
d
 
porcine gonadotropin releasing hormone receptor; 
e
 porcine beta-actin  
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Statistical Analysis 
 The same statistical analyses were used in both experiments. To determine the 
effect of day on plasma concentrations of estradiol-17, hypothalamic concentrations of 
kisspeptin-54 and anterior pituitary concentrations of kisspeptin-54, IGF-I, and LH, 
statistical analyses were performed using the GLIMMIX Procedure of SAS 9.3 (SAS 9.3, 
SAS) to compare pubertal and peripubertal gilts. The model for determining differences 
in estradiol-17 was Yijkl =  + Pigi + Pubertal Statusj + Pigi(Pubertal Status)j + Dayk + 
Pubertal Statusj x Dayk +Pigi(Pubertal Status)j x Dayk + eijkl with repeated measures. Pig 
within treatment by day was the subplot error term used to test pig, day, and pubertal 
status by day effects. The model for determining hypothalamic concentrations of 
kisspeptin and anterior pituitary concentrations of kisspeptin, IGF-I, and LH was Yijk =  
+ Pigi + Pubertal Statusj + Pigi(Pubertal Status)j + eijk. Pig within pubertal status was the 
whole plot error term used to test the effect of treatment.  
 Fold differences in expression of MBH Kiss1 and Kiss1R and AP LH- and 
GnRHR among treatments were determined using the Relative Expression Software Tool 
(REST; Corbett Research and M. Pfaffl, Technical University Munich). The expression 
of a target gene is standardized by a non-regulated gene. Relative expression is based on 
the expression ratio of a target gene versus a reference gene. The expression ratio results 
of the investigated transcripts were tested for significance by Pair Wise Fixed 
Reallocation Randomized Test (Pfaffl et al., 2002).  
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Results – Experiment 1 
To confirm that gilts had not cycled before both experiments, ovaries were 
examined post-slaughter and no corpora lutea, corpora albicantia, or corpora 
hemmorhagica were found.  
Mean plasma concentrations of E2 were not different (P>0.05) in pubertal versus 
peripubertal gilts on d 1 and 3 of the experiment and were greater (P<0.05) within both 
groups of gilts comparing d 1 to 3 of the experiment (Figure 3.1). Mean plasma 
concentrations of E2 were greater (P=0.02) in pubertal versus peripubertal gilts on d 7 of 
the experiment (Figure 3.1). 
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Figure 3.1. Mean plasma concentrations of estradiol-17 in gilts that had (n=8) and had 
not (n=17) attained puberty. Data are expressed as least square means ± SEM. 
abc
Means 
with different letters differ (P<0.05) according to pubertal status and/or day. 
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 No differences were detected (P>0.05) in mean AP concentrations of IGF-I in 
pubertal versus peripubertal gilts (Figure 3.2).   
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Figure 3.2. Mean AP concentrations of IGF-I in gilts that had (n=8) and had not (n=17) 
attained puberty. Data are expressed as least-square means ± SEM.  
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 No differences were detected (P>0.05) in mean AP concentrations of LH in 
pubertal versus peripubertal gilts (Figure 3.3).   
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Figure 3.3. Mean AP concentrations of LH in gilts that had (n=8) and had not (n=17) 
attained puberty. Data are expressed as least-square means ± SEM. 
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 Mean MBH concentrations of kisspeptin were greater (P=0.04) in pubertal gilts 
compared to peripubertal gilts (Figure 3.4). 
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Figure 3.4. Mean hypothalamic concentrations of kisspeptin in gilts that had (n=8) and 
had not (n=17) attained puberty. Data are expressed as least-square means ± SEM. 
ab
Means with different letters differ (P=0.04) by group. 
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Mean relative expression of MBH Kiss1 was up-regulated (P=0.005) 
approximately 2-fold in pubertal gilts compared to peripubertal gilts (Figure 3.5).  
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Figure 3.5. Mean relative expression of hypothalamic Kiss1 in gilts that had (n=8) and 
had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the level 
of Kiss1 by quantitative reverse transcriptase real time PCR with normalization for the 
corresponding level of -actin. Data are expressed as a fold change in expression relative 
to the pigs that had not attained puberty. 
ab
Means with different letters differ (P=0.005) as 
determined by relative expression software tool.  
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 No differences were detected (P>0.05) in mean AP concentrations of kisspeptin in 
pubertal versus peripubertal gilts (Figure 3.6).   
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Figure 3.6. Mean anterior pituitary concentrations of kisspeptin in gilts that had (n=8) 
and had not (n=17) attained puberty. Data are expressed as least-square means ± SEM. 
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 Mean relative expression of AP LH- did not differ (P>0.05) in pubertal versus 
peripubertal gilts (Figure 3.7). 
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Figure 3.7. Mean relative expression of anterior pituitary LH- in gilts that had (n=8) 
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the 
level of LH- by quantitative reverse transcriptase real time PCR with normalization for 
the corresponding level of -actin. Data are expressed as a fold change in expression 
relative to the pigs that had not attained puberty. 
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 Mean relative expression of AP GnRHR did not differ (P>0.05) in pubertal versus 
peripubertal gilts (Figure 3.8). 
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Figure 3.8. Mean relative expression of anterior pituitary GnRHR in gilts that had (n=8) 
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the 
level of GnRHR by quantitative reverse transcriptase real time PCR with normalization 
for the corresponding level of beta-actin. Data are expressed as a fold change in 
expression relative to the pigs that had not attained puberty. 
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Results – Experiment 2 
Mean plasma concentrations of E2 were not different (P>0.10) in pubertal versus 
peripubertal gilts on d 2, 4, and 8 of the experiment (Figure 3.9). Mean plasma 
concentrations of E2 tended to be greater (P=0.06) on d 4 and were greater (P=0.02) on d 
6 in pubertal versus peripubertal animals (Figure 3.9).  
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Figure 3.9. Mean plasma concentrations of estradiol-17 in gilts that had (n=8) and had 
not (n=17) attained puberty. Data are expressed as least square means ± SEM. 
ab
Means 
with different letters differ (P<0.05) according to pubertal status and/or day. 
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No differences were detected (P>0.05) in mean AP concentrations of IGF-I in 
pubertal versus peripubertal gilts (Figure 3.10).   
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Figure 3.10. Mean AP concentrations of IGF-I in gilts that had (n=8) and had not (n=17) 
attained puberty. Data are expressed as least-square means ± SEM.  
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 Mean AP concentration of LH were less (P=0.01) in pubertal versus peripubertal 
gilts (Figure 3.11). 
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Figure 3.11. Mean AP concentrations of LH in gilts that had (n=8) and had not (n=17) 
attained puberty. Data are expressed as least-square means ± SEM. 
ab
Means with 
different letters differ (P=0.01) by group. 
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 No differences were detected (P>0.05) in mean MBH concentrations of kisspeptin 
in pubertal versus peripubertal gilts (Figure 3.12). 
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Figure 3.12. Mean hypothalamic concentrations of kisspeptin in gilts that had (n=8) and 
had not (n=17) attained puberty. Data are expressed as least-square means ± SEM. 
 
 
 
 
 
 
 
 
 
72 
 
 Mean relative expression of MBH Kiss1 did not differ (P>0.05) in pubertal versus 
peripubertal gilts (Figure 3.13). 
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Figure 3.13. Mean relative expression of hypothalamic Kiss1 in gilts that had (n=8) and 
had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the level 
of Kiss1 by quantitative reverse transcriptase real time PCR with normalization for the 
corresponding level of -actin. Data are expressed as a fold change in expression relative 
to the pigs that had not attained puberty. 
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 Mean AP concentrations of kisspeptin-54 were greater (P=0.04) in pubertal versus 
peripubertal gilts (Figure 3.14). 
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Figure 3.14. Mean anterior pituitary concentrations of kisspeptin in gilts that had (n=8) 
and had not (n=17) attained puberty. Data are expressed as least-square means ± SEM. 
ab
Means with different letters differ (P=0.04) by group. 
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Mean relative expression of AP LH- did not differ (P>0.05) in pubertal versus 
peripubertal gilts (Figure 3.15). 
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Figure 3.15. Mean relative expression of anterior pituitary LH- in gilts that had (n=8) 
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the 
level of LH- by quantitative reverse transcriptase real time PCR with normalization for 
the corresponding level of -actin. Data are expressed as a fold change in expression 
relative to the pigs that had not attained puberty. 
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 Mean relative expression of AP GnRHR did not differ (P>0.05) in pubertal versus 
peripubertal gilts (Figure 3.16). 
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Figure 3.16. Mean relative expression of anterior pituitary GnRHR in gilts that had (n=8) 
and had not (n=17) attained puberty. Total RNA was DNase treated and analyzed for the 
level of GnRHR by quantitative reverse transcriptase real time PCR with normalization 
for the corresponding level of beta-actin. Data are expressed as a fold change in 
expression relative to the pigs that had not attained puberty. 
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Discussion 
 Plasma concentrations of E2 increase as animals approach puberty, which occurs 
at a time around standing estrus. This increase in E2 causes the preovulatory GnRH and 
LH surge. Gonadotropin releasing hormone neurons are scattered throughout the 
hypothalamus and are considered to be the gatekeepers for the attainment of puberty, 
however, new research indicates there may be several factors controlling the attainment 
of puberty, including kisspeptin (Silverman et al., 1987; Silverman et al., 1979). Because 
research is equivocal as to whether GnRH neurons possess estrogen receptors it is 
thought that other factors contribute to the attainment of puberty.  
 Kisspeptin is a neurohormone that is produced by the Kiss1 gene (Kotani et al., 
2001). Kisspeptin and kisspeptin neurons have been demonstrated to associate intimately 
with GnRH neurons in the hypothalamus (Hrabovszky et al., 2007). It was reported that 
deletions or mutations in GPR54 in the mouse resulted in infertility and the failure to 
attain puberty (de Roux et al., 2003; Seminara et al., 2003). Additionally, deletions and 
mutations in the Kiss1 gene in humans and mice have been associated with difficulties in 
the attainment of puberty (d'Anglemont de Tassigny et al., 2007; Lapatto et al., 2007). 
These data support the notion that the hypothalamic kisspeptin system is associated with 
the attainment of puberty in multiple mammalian species. 
 Plasma concentrations of estradiol-17 have been demonstrated to be increased 
during the attainment of puberty in gilts (Karlbom et al., 1982). In the present studies, 
plasma concentrations of E2 were the same among all animals upon their arrival in both 
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experiments. By the end of experiment 1, gilts that were considered to be pubertal by 
exhibiting a standing estrus response had greater plasma concentrations of E2 than gilts 
that were considered peripubertal. Gilts in experiment 2 were slaughtered a day later, 
however, there was no difference in plasma concentrations of E2, but plasma 
concentrations of E2 were greater on d 6 (2 days prior) in gilts that had attained puberty 
versus gilts that were peripubertal. It is worth noting that this difference in plasma 
concentrations of E2 may influence MBH and AP concentrations of hormones comparing 
the puberty experiments. Therefore, it is apparent that the timing of sample collection and 
which day gilts are slaughtered greatly affected plasma concentrations of E2.  
 In both experiments there was no difference in AP concentrations of IGF-I in gilts 
that pubertal compared to gilts that were peripubertal. Clapper and Taylor (2011) 
demonstrated that on d 19 of the estrous cycle AP concentrations of IGF-I were greater 
than on d 7, 13, or 22 of the estrous cycle. Insulin-like growth factor I has also been 
shown to have positive effects on the LH surge in a number of species (Adam et al., 
2000; Stewart et al., 1996). In addition to its effects on LH, IGF-I has also been shown to 
induce an increase in hypothalamic expression of Kiss1 mRNA during the onset of 
puberty in rats (Hiney et al., 2009). Hiney et al. (2009) also demonstrated that when rats 
were administered an IGF-I inhibitor there was a decrease in hypothalamic Kiss1 mRNA 
expression in the rat. Therefore, it is plausible that IGF-I may influence hypothalamic 
concentrations of kisspeptin and expression of Kiss1 mRNA, however, the exact 
mechanism has not been determined. Previous research has indicated that the effects of 
IGF-I are modulated by insulin-like growth factor binding proteins (IGFBP) (Bourner et 
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al., 1992; Ling et al., 1993). Insulin-like growth factor binding proteins can have either 
inhibitory or stimulatory effects (Mohan and Baylink, 2002), which can also be tissue 
specific (Hoeflich et al., 2000; Slootweg et al., 1995). Additionally, direct actions of 
IGFBP that are independent of IGF-I may exist (Andress, 1998). It is plausible that 
IGFBP may contribute in the regulation of the hypothalamic kisspeptin system, however 
they were not quantified in the present experiments. 
 Puberty in the gilt can be defined as the first time the gilt expresses a standing 
estrus. It is widely accepted during the attainment of puberty the preovulatory LH surge 
occurs followed by ovulation approximately 24-36 h later (Driancourt et al., 2013). 
Although the LH surge was not measured in this experiment it occurs during the time 
before a standing estrus in the gilt. In the first experiment there was no difference in AP 
concentrations of LH in pubertal versus peripubertal gilts. However, in the second 
puberty experiment there were decreased AP concentrations of LH in gilts that had 
attained puberty versus peripubertal gilts. Comparing this with MBH and AP 
concentrations of kisspeptin and hypothalamic Kiss1 mRNA expression, there is an 
apparent difference in hormone levels when gilts are slaughtered one day later with 
respect to the start of boar exposure. In the first experiment both hypothalamic Kiss1 
mRNA expression and MBH concentrations of kisspeptin were greater in gilts that had 
attained puberty compared to peripubertal gilts. In the second puberty experiment there 
were no differences in hypothalamic Kiss1 mRNA expression and MBH concentrations 
of kisspeptin comparing pubertal and peripubertal gilts. During the attainment of puberty 
there is an increase in hypothalamic Kiss1 mRNA expression in rodents and sheep 
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(Navarro et al., 2004; Shahab et al., 2005), which correlates with the first puberty 
experiment. Although the second experiment does not correlate with previous research, 
we think it is due to timing of sample collection.  
There was no difference in AP concentrations of kisspeptin between pubertal and 
peripubertal gilts in the first experiment, however AP concentrations of kisspeptin were 
greater in gilts that were pubertal compared to gilts that were peripubertal in the second 
study. When gilts were slaughtered a day later there was a decrease in AP concentrations 
of LH in pubertal gilts versus peripubertal gilts as well as an increase in AP 
concentrations of kisspeptin. Navarro et al. (2004) demonstrated that central 
administrations of kisspeptin increased plasma concentrations of LH in female rats 
compared to controls. Also, repetitive administration of kisspeptin to prepubertal female 
lambs increased plasma concentrations of sex steroids as well as caused the preovulatory 
LH surge (Redmond et al., 2011). In experiment 1 there was an increase in plasma 
concentrations of E2 in pubertal gilts versus peripubertal gilts on the day gilts were 
slaughtered. On the same day, there was also an increase in hypothalamic concentrations 
of kisspeptin and MBH expression of Kiss1, however, there was no difference in AP 
concentrations of kisspeptin and LH comparing pubertal to peripubertal gilts. 
 In experiment 2 there was no difference in plasma concentrations of E2 between 
treatments on the day gilts were slaughtered (d 8), however, plasma concentrations of E2 
were greater on d 6 in pubertal animals. Additionally, there was no difference in 
hypothalamic concentrations of kisspeptin and expression of Kiss1 between treatments, 
however, there was an increase in AP concentrations of kisspeptin and a decrease in 
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concentrations of LH in pubertal gilts in the second study. A plausible mechanism could 
be that hypothalamic expression of Kiss1 is increasing at a time temporally related with 
an increase in release of AP LH (Lents et al., 2008; Sebert et al., 2010; Whitlock et al., 
2008). At a time coincident with an increase in hypothalamic expression of Kiss1 there 
was an increase in hypothalamic concentrations of kisspeptin in the present study. 
Kisspeptin receptor expression and kisspeptin receptors have been found to be co-
expressed with GnRH neurons in the hypothalamus and in the AP (Hrabovszky et al., 
2007; Irwig et al., 2004; Li et al., 2012). Additionally, peripheral administration of 
kisspeptin-54 has been shown to activate GnRH neurons in the hypothalamus (Caraty et 
al., 2007). Therefore, an increase in MBH and/or AP concentrations of kisspeptin may 
increase kisspeptin receptor binding in the MBH and/or AP potentially causing the 
increased release of GnRH and/or LH, respectively. Although the exact mechanism of the 
interaction of AP LH and MBH and AP kisspeptin in the pig is not fully understood, 
these data indicate the existence of this possible mechanism.  
 Although no differences were found in AP expression of LH- and GnRHR 
mRNA between treatments in the present studies, it is plausible that during the attainment 
of puberty, which is coupled with an increase in peripheral concentrations of E2, there is 
an up-regulation of AP expression of LH- and GnRHR. During the time of the 
preovulatory LH surge AP LH- and GnRHR mRNA expression are up-regulated in the 
rat (Haisenleder et al., 1988; Seong et al., 1998). Luteinizing hormone subunit-beta 
confers the biological activity of LH and at times during the preovulatory LH surge AP 
LH- mRNA expression is up regulated nearly 3-fold in the rat (Haisenleder et al., 1988). 
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Under the influence of both progesterone and estrogen, rats exhibited an increase in AP 
expression of GnRHR mRNA compared to rats that were only under the influence of 
estrogen (Seong et al., 1998). Turzillo et al. (1994) found that E2 caused an increase in 
AP expression of GnRHR mRNA in the ewe. Although no differences in AP expression 
of GnRHR and LH- were found in the present experiments, we believe that the timing 
of sample collection and/or species differences may have impacted our results. 
Haisenleder et al. (1988) found differences in the rat, however, our timing was not as 
precise as theirs due the rat having a shorter estrous cycle.  
 Timing is critical in detecting differences in hormone concentrations that occur 
during the peripubertal period. Following relocation and boar exposure, which caused 
gilts to attain puberty, there were differences in MBH and AP concentrations of 
kisspeptin and Kiss1 mRNA expression in gilts slaughtered 7 days versus gilts 
slaughtered 8 days following the start of boar exposure. Although there were variations in 
hypothalamic, anterior pituitary, and peripheral levels of hormones in the present studies 
due to timing, changes within the hypothalamic kisspeptin system are consistent with 
what is found in other mammalian species.  
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Chapter 4 
Summary and Conclusions 
 The results of these experiments provide evidence that MBH and AP 
concentrations of kisspeptin and Kiss1 mRNA expression differ throughout the estrous 
cycle and during the peripubertal period. The levels of MBH, AP, and plasma hormones 
seemed to be equivocal comparing both of the puberty experiments. Timing of sample 
collection is important when measuring tissue hormone levels throughout the estrous 
cycle and during the attainment of puberty. It is plausible that kisspeptin may be a driving 
factor in the GnRH and LH surge, which is a time temporally related with a standing 
estrus.  
 During the estrous cycle there were increased levels of AP LH on d 14 versus d 
21 of the estrous cycle, indicating that the AP released LH between those times and the 
preovulatory LH surge had occurred. At a time temporally related with the released of AP 
LH, hypothalamic Kiss1 mRNA expression was 2.5-fold greater versus when AP 
concentrations of LH were increased. Relative expression of MBH ER- mRNA was also 
down regulated at a time coincident with increased MBH Kiss1 mRNA expression and a 
standing estrus. This decrease in expression may have been caused by kisspeptin or other 
reproductive hormones during a standing estrus, which is temporally related with the 
preovulatory LH surge.  
 During the first experiment of the puberty study gilts were slaughtered on d 7 and 
there was increased hypothalamic expression of Kiss1 and increased MBH concentrations 
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of kisspeptin in pubertal versus peripubertal gilts. This occurred during the time when 
gilts stood in estrus; a time temporally related with the preovulatory LH surge. During the 
second experiment of the puberty study gilts were slaughtered on d 8 and there were no 
differences in hypothalamic Kiss1 expression and MBH concentrations of kisspeptin 
between treatments, however, AP concentrations of kisspeptin were greater in pubertal 
gilts compared to peripubertal gilts. Pubertal gilts also had decreased AP concentrations 
of LH versus peripubertal gilts. This indicates that an increase in AP concentrations of 
kisspeptin and a decrease in AP concentrations of LH occur at a time coincident with 
each other and during a standing estrus. It is plausible that this occurred because 
kisspeptin was released from the hypothalamus into the hypothalamo-pituitary portal 
plexus, traveled to the AP, and in concert with GnRH, caused the release of LH.  
 Therefore, these studies agree with previous research and support the notion that 
during the time of a standing estrus and the expected preovulatory LH surge, there was an 
increase in hypothalamic Kiss1 expression and/or an increase in MBH and/or AP 
concentrations of kisspeptin.  
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